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THE RETINA-PROSTHESIS INTERFACE IN TWO RAT MODELS  
OF RETINITIS PIGMENTOSA AND FUNCTIONAL CHANGES  
ASSOCIATED WITH PHOTORECEPTOR LOSS 
 
James W. Fransen 
 
June 28th, 2013 
  
With increasingly successful clinical trials, the use of prosthetic devices to 
replace the function of photoreceptors has now become a viable option to treat 
degenerative diseases of the retina, including age-related macular degeneration 
(AMD) and retinitis pigmentosa (RP). Using prosthetics, patients have 
demonstrated the ability to read large text, recognize small objects, and navigate. 
While promising, this represents coarse visual function, with the highest visual 
acuity equivalent to 20/560, still below the legal definition of blindness, 20/200. 
To investigate the benefit of more sophisticated designs, I implanted two types of 
photovoltaic prosthetic devices in two models of RP, Tg S334ter-3 and Tg P23H-
1 rats. The performance of a new bipolar photovoltaic array (bPVA) design with 
local ground returns was compared to a monopolar photovoltaic array (mPVA) 
with a single ground return. Regardless of implant design, stimulation parameters 
at threshold were at least 1.5 orders of magnitude below safety limits. Age and 
duration of implantation had no significant effect on stimulation thresholds while 
threshold increased inversely to pixel size. 
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In addition to treating the symptoms of these diseases, a better 
understanding of the functional consequences of degeneration will help guide 
future treatment strategies. I examined changes in visual function in the retina 
and the superior colliculus (SC). I found profound changes in visual function in 
both models. First, the ON pathway is preferentially lost due to a shift from equal 
numbers of ON and OFF ganglion cells in the retina and ON dominated 
responses in the SC to OFF dominated responses in both. In the Tg P23H-1 rat, 
this shift is progressive with age, while in the Tg S334ter-3 this shift is evident 
early in life. In late stages of the disease, there is little response from the ON 
pathway. In animals implanted with bPVA devices, there was a significant 
change in the response based on the location of the prosthesis, with a 
preservation of the ON pathway in areas directly under the influence of the 
prosthesis. Either the presence of the device or basal electrical activity may 
induce a trophic influence that attenuates this change in visual function. 
vi 
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INTRODUCTION AND GENERAL 
BACKGROUND INFORMATION 
 
Regardless of species, the need for an organism to gather information 
about its environment is universal. Tactile, chemical, and photic stimuli have all 
driven the evolution of different sensory modalities to best detect stimuli 
contained in an organism’s natural environment. The ability to detect light, food 
sources and environmental danger led to the development of visual systems 
early in evolutionary history. Early vision was likely very simple, consisting of little 
more than aggregations of proteins in bacteria that drove phototaxis. These 
proteins were able to change conformation in response to the presence or 
absence of light. Providing feedback to the organism, this change could then be 
used to drive the bacterium towards or away from a source of light depending on 
the needs of the organism (Suzuki et al., 2010).This rudimentary system evolved 
along with the diversity of life over billions of years to provide more thorough and 
sophisticated visual information regarding the environment. The study of the 
visual system has revealed an exquisitely tuned system for collecting and 
interpreting visual signals in the specific environment of a species. Visual 
systems have evolved to the circadian cycle, food source, predatory species, etc.
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contained in an organism’s specific environment. For example, bees (Skorupski 
and Chittka, 2010) and mice (Jacobs et al., 1991) can detect light in the ultra-
violet (UV) spectrum, below the visible wavelengths of humans. This sensitivity to 
UV wavelengths increases the bee’s ability to find specific food sources in the 
form of flowers that reflect UV light. The visible spectrum for humans is at least 
partially tied to food source as well. In a similar fashion, it is hypothesized that 
humans developed color perception at least in part to better assess the ripeness 
of fruits and vegetables, which is related to its nutritional value (Lucas et al., 
2003). These are but a small fraction of examples that could be used to highlight 
the importance of the visual system to most organisms. Given the importance of 
environmental stimuli to an organism, deficits in any sensory system can be 
devastating. Within the visual system, mutations in the proteins that begin the 
process of phototransduction can lead to debilitating visual deficits or even 
complete blindness. The general goals of this dissertation are to assess a 
potential treatment for blinding eye diseases in the form of retinal prosthetic 
devices, describe functional changes that occur in the retina and its first synapse 
as a result of photoreceptor degenerative processes, and address the possibility 
that implantation of a prosthetic device may impart a neuroprotective effect on 







The Visual System and Phototransduction 
Retinal Structure and Cell Classes 
The retina is a neural structure that 
contains five general cell classes. These 
cells form a laminar structure in which three 
cellular layers alternate with two plexiform 
(synaptic) layers (Figure 1). The 
photoreceptor cell bodies form the first 
cellular layer, the outer nuclear layer (ONL). 
In the outer plexiform layer (OPL), 
photoreceptors synapse with cells of the 
inner nuclear layer (INL), namely the 
bipolar cells (BCs) and the horizontal cells 
(HCs), which modulate the photoreceptor 
output. The BCs provide the excitatory drive to amacrine cells (ACs), also located 
in the INL and both BCs and ACs synapse onto retinal ganglion cells (RGCs) in 
the inner plexiform layer (IPL). RGCs are projection neurons whose axons exit 
the back of the eye to form the optic nerve and transmit signals to the visual 
centers of the brain.  
 
Phototransduction 
Phototransduction is the conversion of light into an electrical signal within the 
photoreceptor. Photosensitivity within photoreceptors arises due to the presence 
Figure 1. Laminar structure of the 





of photopigments, called opsins, in the outer segment (OS) (Figure 2). In the 
dark, cGMP-gated cation channels in the photoreceptor outer segments are in an 
open state. Current flows into the outer segment (the ‘dark current’), the 
photoreceptors depolarize and in the dark release glutamate. In the inactive 
state, opsin proteins are bound to a trimeric g-protein, called transducin, which is 
composed of an alpha, beta, and gamma subunit. In the dark, GDP is attached to 
the alpha subunit and keeps it bound to the beta and gamma transducin 
subunits. When a photoreceptor absorbs a photon, 11-cis retinal changes 
conformation to all-trans form and activates rhodopsin. Once rhodopsin is 
activated, the GDP bound to the alpha transducin subunit is phosphorylated to 
GTP and the alpha subunit is released. The now activated alpha subunit is free 
to bind and activate cGMP phosphodiesterase. This enzyme catalyzes the 
hydrolysis of cGMP to a non-cyclic form, with the decrease in cGMP closing the 
cation channels and hyperpolarizes the photoreceptor. This decreases glutamate 




There are two classic types of retinal photoreceptors: rods and cones. 
Because of their differential sensitivity to light, these two types give the retina the 
ability to work over a luminance range of about 12 orders of magnitude. The rods 
are more sensitive than the cones, with the ability of a rod to respond to a single 
absorbed photon (Baylor et al., 1979). To achieve high sensitivity, rods pool their 
signals at subsequent synapses, but the consequence is poor spatial resolution 
under rod driven vision. Therefore, rods are utilized under low light conditions 
when the ability to detect light and movement are more important than resolution. 
Cones are active during higher ambient light conditions and their nearly “one to 
one” synaptic connections in the fovea result in high acuity. Because cones can 
express one of two or three opsins (depending on the species) with different 
spectral sensitivities, they initiate color perception. 
 
Figure 2. A. Structure of cone and rod photoreceptors. B. The elements of the 
phototransduction cascade. Adapted from: Left: The Visual Neurosciences 





Normal Retinal Signaling 
The photoreceptor's reduction in glutamate release causes a change in the 
polarization of their postsynaptic partners, the BCs and HCs. The sign of the 
polarization depends on the type of glutamate receptor expressed by the HCs 
and the ten morphological types of BC. There are four morphological types of 
OFF cone BCs which express ionotropic glutamate receptors (iGluRs), which are 
comprised of a cation channel with a glutamate receptor binding site. iGluRs 
open when glutamate binds and depolarize then quickly desensitize due to the 
properties of the channel. When glutamate concentrations in the synapse are low 
(in the light), the iGluR channel is closed, similar to the closure of the channels in 
the photoreceptor. This means that the OFF BCs conserve the sign of the 
photoreceptor signal (hyperpolarization) to light and depolarize at the onset of a 
luminance decrement.  
There are five types of ON cone BCs and one type of ON rod BC that express 
metabotropic glutamate receptor type 6 (mGluR6), which is a G-protein coupled 
receptor. When glutamate concentrations are low in the synapse, a G-protein 
cascade is inhibited and the non-specific cation channel, TRPM1, is opened. In 
the dark when glutamate concentrations are high, the G-protein cascade is 
initiated which closes the TRPM1 channel. In this way, ON BCs invert the sign of 
the photoreceptor signal; when the photoreceptor is hyperpolarized, the BC will 
depolarize. At this first synapse, the opposite BC responses create the ON (BCs 
with mGluRs) and OFF (BCs with iGluRs) parallel signaling pathways within the 
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retina. At this synapse, horizontal cells use feedback inhibition to modulate 
photoreceptor output and to generate an inhibitory surround in the BCs.  
Within the cone pathway, photoreceptors signal to ON and OFF cone BCs, 
which synapse directly onto RGCs and generate an excitatory input via 
glutamate release. Rod BCs are ON BCs, but do not directly synapse onto 
RGCs. Instead, they utilize a narrow field bistratified 
AC, the AII AC, as an intermediary to provide input to 
both the ON and OFF cone pathways but the AII 
connects to each with a different mechanism. The AII 
AC connects to ON cone BCs through a gap junction, 
creating a signal of the same sign as the presynaptic 
input. The AII connects to OFF cone BCs or OFF 
RGCs via an inhibitory synapse, releasing glycine to 
inhibit the OFF pathway (Figure 3). With these 
connections the AII AC is able to convey information 
to both pathways: excitation to the ON pathway and 
inhibition to the OFF pathway during rod driven vision. 
BCs signal to RGCs via glutamate and ACs modulate 
the BC signal via a number of inhibitory mechanisms 




Figure 3. The rod signaling 
pathway. Rod photoreceptors 
provide synaptic input to rod 
BCs. These interneurons 
connect to both the On 
pathway via the AII amacrine 
cell. The AII makes a gap 
junctional contact with OFF 
BCs, while it makes a 
glycinergic synaptic contact  
with ON cone BCs. r=rod, 
c=cone, rb=rod BC, cb=cone 
BC, AII=AII AC, gc=RGC. From 




The Superior Colliculus 
The superior colliculus (SC) is a subcortical structure that is a direct synaptic 
target of RGC axons. In mice, it is estimated that at least 70% of RGCs make 
synaptic connections with cells in the SC (May, 2006). The SC is organized as a 
laminar structure. The superficial (dorsal) layers receive synaptic input primarily 
(~95-98%) from contralateral RGC axons, whereas the more ventral layers 
process other sensory modalities or integrate multi-sensory information (May, 
2006). The most likely function of the SC is to direct attention towards a novel or 
moving stimulus (Robinson, 1972). For most animals, this plays a vital role in the 
ability to spot prey or avoid predators. The SC provides input to the lateral 
geniculate nucleus (LGN) (Hoffman, 1973), another direct synaptic target of RGC 
axons, and receives input from the primary visual cortex (Lund, 1964). These 
connections lead to the hypothesis that the SC likely has a modulatory role for 
image formation and is modulated by the input from V1, although the specific 
functions of these connections are not as well understood.  
The axons of the RGCs form a topographic map of the retina on the dorsal 
surface of the SC (Figure 4). This means adjacent RGCs within the retina 
synapse at adjacent points across the SC dorsal layers (Drager and Hubel, 
1976). This spatial information about regional changes within the retina also can 





Retinitis Pigmentosa and Rat Models of RP 
Causes of RP 
 Retinitis pigmentosa is a group of disorders characterized by the loss of 
rod photoreceptors and in many cases, subsequent loss of cone photoreceptors. 
The majority of cases of RP result from mutations in rhodopsin or its signaling 
cascade. This can lead to difficulty with peripheral vision or low light vision, such 
as driving at night, which typically are the first symptoms that push patients to 
see their doctor. Upon examination, the typical signs of RP in the fundus include 
bone spicule formation, arteriolar atrophy and optic disc pallor, which are 
accompanied by a reduced electroretinogram (ERG) response (Fishman et al., 
1988; Figure 5). 
Figure 4. Retinal 
projections to the 
dorsal surface of the 
left SC. Labels inside 
the diagram represent 
the projections from 
RGCs. Labels outside 
the diagram represent 
































While many patients present with similar signs and symptoms, the genetic 
cause varies extensively. Mutations in a number of different genes cause RP, for 
example, mutations in rhodopsin (Dryja et al., 1990), in genes expressed by the 
retina pigment epithelium (RPE) (Thompson et al., 2002), in photoreceptor 
transcription factors (Martinez-Gimeno et al., 2001), and in accessory proteins 
associated with photoreceptors (Kimberling et al., 1990). Even with the reduced 
price and increased access of genetic testing to the public, up to 40% of genetic 
causes of RP remain unknown (Hartong et al., 2006). In addition, RP is inherited 
in multiple ways; some are autosomal dominant (ADRP), others autosomal 
recessive or X-linked. This heterogeneity in mutation and inheritance means that 
any potential genetic therapy approach is unlikely to be universally applicable. As 
a consequence, other therapeutic approaches are being developed to treat RP. 
They include: neuroprotection to delay degeneration, cellular therapies with the 
hope of replacing lost photoreceptors, optogenetic expression of bacterial 
Figure 5. A: Fundus image of normal retina. B: Fundus image of advanced RP 
patient, note the appearance of bone spicules, optic disc pallor, and blood 




channel opsins to replace lost photoreceptor function and finally, prosthetic 
devices (including retinal, optic nerve, LGN and cortical).  
 
Transgenic (Tg) P23H-1 and S334ter-3 Rat Models of RP 
 Once the genetic causes of RP started to be defined, multiple animal 
models of RP were found or created using molecular manipulation. These 
include mice (Olsson et al., 1992, McNally et al., 2002, Price et al., 2011), rats 
(Bok and Hall 1971, Lewin et al., 1998, Liu et al., 1999), rabbits (Kondo et al., 
2009) and pigs (Petters et al., 1997, Ross et al., 2012). Two Tg rat models (with 
multiple lines in each) that express rhodopsin mutations, P23H and S334ter have 
been widely used. The Tg P23H-1 rat results from a single point mutation that 
alters the 23rd amino acid residue in rhodopsin from a proline to a histidine in the 
mutated protein (Lewin et al., 1998). This amino acid change prevents the mutant 
rhodopsin from folding properly. Deficiencies in the ubiquitin protease system 
associated with these mutations lead to the accumulation of the mutant protein in 
the photoreceptor cell body and cause apoptosis (Illing et al., 2002). The P23H 
mutation is the most common form of ADRP in North America, accounting for 
12% of all cases (Dryja et al., 1990).  
The Tg S334ter-3 rat results from a point mutation that causes an early 
stop codon at the 334th residue, normally a serine (ucsfeye.net). This change 
results in the expression of a truncated rhodopsin protein in which 15 amino 
acids are lost from the C-terminus, which results in the inability to properly traffic 
rhodopsin to the outer segments (Concepcion et al., 2002). Like mutant P23H 
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rhodopsin, this protein also accumulates in the photoreceptor cell body and 
causes apoptosis (Shinde at al., 2012). Within each model there are multiple 
lines distinguished by their different rates of degeneration, which most likely 
arises from positional effects of transgene insertion and differential expression of 
the transgene. Line number is designated at the end of the name, for example Tg 
P23H-1 represents line 1.  
Both Tg P23H-1 and Tg S334ter-3 models show initial rod photoreceptor 
death followed by cone photoreceptor death at later stages, much like the course 
of human RP. Both models show autosomal dominant inheritance patterns, 
similar to some human RP patients. These models were chosen, for my 
experiments in order to contrast and compare a fast (Tg S334ter-3) and a slow 
degeneration line (Tg P23H-1). The rates of degeneration have been measured 




Figure 6. Degeneration rates differ across Tg P23H and Tg S334ter 
rat lines. Tg P23H line 1 and Tg S334ter line 3 rats were used for my 





COMPARISON OF THE RETINA-PROSTHESIS 
INTERFACE OF TWO SUBRETINAL PHOTOVOLTAIC 
ARRAY DESIGNS IN A RAT MODEL OF  
RETINITIS PIGMENTOSA 
 
Introduction and Background 
Many blinding eye diseases result from photoreceptor dysfunction and 
degeneration. When this occurs, vision can be severely impaired and visual 
perception may be lost completely. The most prevalent degenerative 
photoreceptor diseases include AMD and RP. Together they affect approximately 
1.9 million people in the United States and this number is expected to increase to 
nearly three million within the next eight years as the baby boom generation 
continues to age (Friedman et al., 2004). Currently, patients have few treatment 
options and most therapies only delay disease progression. In AMD and RP, 
although photoreceptors are lost, most of the other retinal cell classes remain; 
including BCs, ACs and RGCs. The pathways through the retina initiate visual 
image formation and send input to all higher visual centers in the brain. Thus, 
many therapies aim to either replace the cells themselves or replace their 
function. At present, there is no proven cellular therapy to replace lost 
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photoreceptors. Other strategies include optogenetic expression of a bacterial 
opsin in the remaining BCs and/or RGCs or replacement of photoreceptor 
function with a prosthetic device.  
Retinal neurons use changes in electrical potential to generate chemical 
signals that transmit information across synapses, thus applied external electrical 
current can stimulate neurons of the retina (Gebhard, J.W. 1952, Kurosawa 
1954). As a potential treatment for the loss of photoreceptors, a retinal prosthetic 
that responds to light and produces current should be capable of stimulating the 
BC/RGC pathway. A highly proficient prosthetic device will have a high density of 
electrodes; ideally it will emulate the ratio of electrode to BC similar to that found 
between retinal photoreceptors and BCs. For optimal spatial coding, the 
electrode size should be small but also provide sufficient current to stimulate a 
small number of BCs over the extent of their dendritic arbor to theoretically 
increase spatial resolution. Stimulation thresholds should be low and there 
should be a linear range of current to response to emulate the graded response 
of the photoreceptor itself. To be of use for a majority of patients, the 
prosthetic/retina interface should be established regardless of disease 
progression and should remain intact over a long time period. While devices such 
as this have been made and tested previously, their design has produced limited 
spatial discrimination. Towards the goal of a high-resolution prosthetic device, a 
design has recently been produced to address these spatial limitations 
(Mathieson et al., 2012). With this new design, current spread is theoretically 
15 
 
more localized with the idea that it will enhance spatial acuity and the resolution 
for an implanted patient. 
 
Applied Electrical Stimulation 
 The ability of electrical stimulation to reliably elicit light perceptions 
(phosphenes) in completely blind patients (Humayun et al., 1999) supports the 
possibility that photoreceptor function can be replaced using implanted prosthetic 
devices. Direct stimulation of the RGCs results in a 1:1 ratio of pulse to action 
potential while stimulating the BCs results in a burst of RGC activity 
(Eikenscheidt et al., 2012). This supports the theory that stimulating through BCs 
allows the signal to be processed by the retinal circuit, potentially leading to a 
better approximation of normal vision. Importantly, multiple studies have reported 
that thresholds are the same when stimulating either through BCs or RGCs 
directly (O’Hearn et al., 2006, Shah et al., 2006, Shyu et al., 2006). If thresholds 
are the same regardless of the site of stimulation, then the better site should be 
the one that best approximates the normal flow of the visual signal.  
  
The Photovoltaic Effect 
Prosthetic devices have multiple designs to create the electrical activity that 
drives the postsynaptic cells. Most prosthesis designs utilize an external power 
source to drive the device and deliver current to the retinal cells. An external 
power supply is particularly useful for devices implanted in parts of the visual 
system that cannot be directly stimulated by light, such as the optic nerve. When 
16 
 
a prosthetic device is placed in the eye, it is possible to use light to generate 
electric current directly from the device in a process known as the photovoltaic 
effect. This is the same technology that solar panels use to convert sunlight into 
energy to power our homes and cities. The process relies on the chemical 
properties of semiconductor materials such as germanium, selenium, gallium, 
telluride, and the most common material used, silicon. (www.eere.energy.gov). 
Crystalline forms of these materials absorb light of sufficient energy and release 
electrons bound in their crystalline lattice to a free conduction energy state. 
When positive and negative diodes are paired, an electric field is introduced, 
which generates current flow between them (pveducation.org). The current 
generated can then be collected, as in solar cells, or in the prosthetic device to 
stimulate the retina. 
 
Prosthetic Devices and the Visual System 
Multiple areas within the visual system are active areas of research for 
prosthetic devices: the retina (Chow et al., 2004, DeMarco et al., 2007, Jensen 
and Rizzo 2008), optic nerve (Veraart et al., 1998), and primary visual cortex 
(Maynard et al., 1997) are all targets. Currently, there is a debate over the best 
placement of a prosthetic device and how to stimulate the retina: trans-scleral, 
suprachoroidal, subretinal or epiretinal (Rettay and Resatz, 2004; Figure 7). 
The trans-scleral approach places the prosthesis outside of the eye on the 
sclera. The current produced spreads through the sclera, choroid and RPE to 
stimulate the retina. The clear advantage to this placement is a minimally 
17 
 
invasive surgery with few risks such as infection or surgical damage to the eye or 
retina. However, there are significant disadvantages to this approach. In 
particular, much higher current is required to stimulate the retina compared to 
intraocular approaches. The 
high current levels may 
adversely affect the sclera 
and other surrounding 
tissues. Further, the 
resolution achieved is 
significantly reduced due to 
lateral current spread along 
the outside of the eye. 
The epiretinal approach 
places the prosthesis within the vitreous cavity, close to the RGCs and their 
nerve fiber layer (NFL). The advantage is that RGCs and their axons are directly 
stimulated, which improves spatial resolution compared to a trans-scleral 
approach. A significant disadvantage is that all current epiretinal designs have 
external power supplies with wires that exit the eye. This creates a permanent 
open surgical site, which increases the risk for complications, such as corneal 
erosion and infections that have been reported in the Argus II trial (Humayun et 
al., 2012). In addition, the wires must be configured to permit the eye and wire to 
move freely. Improper placement increases stress on these wires and may result 
Figure 7. Intraocular implantation approaches for 
retinal prosthetic devices. Modified from Rattay 
and Resatz, 2004. 
18 
 
in catastrophic failure, requiring additional surgery and risk to the patient to 
replace the damaged unit.  
Subretinal and suprachoroidal approaches attempt to stimulate the retina 
from the photoreceptor side. The advantage of stimulating from the INL side is 
that it should stimulate cells in the INL to make use of the inherent circuitry within 
the INL rather than bypassing it and stimulating RGCs directly (Cuenca et al., 
2004). Thus, the signal should be modulated before it is transmitted to the RGCs 
and the rest of the visual system and should result in a better approximation of 
normal vision. To date the interface between the prosthetic devices and the inner 
retina has not been empirically tested in vivo. Whether the current is limited to 
the inner retina or extends to directly stimulate the RGCs remains unknown. In a 
subretinal approach, the prosthesis is inserted within the subretinal space with 
the electrodes of the prosthesis in direct contact with the INL. In contrast, in a 
suprachoroidal approach, the prosthesis is placed on top of the choroid and must 
pass current through the choroid before reaching the INL. The possible 
advantage over subretinal placement is the diffusion of nutrients from the choroid 
may be improved. Although, the work of Pardue and colleagues indicates that the 
absence of nutrient diffusion through a solid device over 8 weeks is not 
detrimental to the underlying retinal morphology in RCS rats (another model of 
RP), when implanted long term (27 weeks) in wild-type cats there was a 
significant loss of photoreceptors directly beneath the device (Pardue et al., 
2001, Pardue et al., 2005). Whether function or the site of stimulation is altered 
over time also has not been addressed. New designs are incorporating pores or 
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channels within the device material to permit better nutrient diffusion. Whether 
this will improve the outcome also has not been tested.  
 
Neuroprotective effects of prosthetic devices and electrical stimulation 
 The direct benefits of prosthetic devices may be augmented by 
neuroprotective effects. Pardue et al. (2005) showed an increased 
electroretinogram (ERG) b-wave amplitude and photoreceptor preservation in 
implanted RCS rats in the area of the implant. Demarco et al. (2007) reported a 
trophic effect in RCS rats implanted with a prosthetic device even when the 
device was an inactive type (non-current producing). Visual responses were 
more robust within the area of the implant when compared to control RCS rats. In 
contrast, the Mertk mouse, which has a similar mutation as the RCS rat, did not 
show a neuroprotective effect from an implanted mPVA (Mocko et al., 2011). In 
addition to effects of prosthetic devices, electrical stimulation has been reported 
to protect axotomized RGCs (Morimoto et al., 2005), preserve photoreceptors (Ni 
et al., 2009, Morimoto et al., 2012) and increase ERG amplitudes (Ni et al 2009). 
The potential for neuroprotective effects has important implications concerning 
when patients may optimally benefit from implantation of a prosthetic device. 
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The mPVA (ASR) and bPVA Designs 
The mPVA retinal prosthetic device was one of the earliest designs used 
in human clinical studies (Figure 8; Optobionics, Inc., Chow et al., 2004, Chow et 
al., 2010). In the RCS rat model of RP, DeMarco et al. (2007) were the first to 
demonstrate the functional efficacy of the mPVA device in a degenerate retina by 
recording prosthesis-evoked activity in the SC. While these were promising 
results, the mPVA design is limited by two important factors. First, the solid wafer 
design limits diffusion of 
nutrients to the retina 
directly under the device 
(Chow et al., 2001) and 
could impact the 
preservation of inner 
retina, exacerbating 
degeneration. Second, 
although the mPVA 
incorporates hundreds of tiny electrodes (each 10μm) on its surface that have the 
potential to generate high acuity vision, its single ground return electrode limits its 
spatial resolution. With the return electrode located on the opposite side of the 
electrodes, current must flow around the prosthesis. The current could potentially 
stimulate any cell along the path it takes, degrading spatial resolution. A new 
photovoltaic prosthetic design (Figure 9; Mathieson et al., 2012) attempts to 
address both nutrient diffusion and current flow. First, the new design has 5 μm 
Figure 8. mPVA type prosthesis. Left: 
The 1 mm MPVA device. Middle: 
Expanded view of the electrode array. 
Right: Magnified view of a single 
electrode in the array. Modified from 
Mathieson et al., 2012. 
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gaps around each electrode 
that should increase nutrient 
diffusion through the 
prosthesis to the retina. The 
design also includes a high 
pixel-density array with 
individual return electrodes 
surrounding each pixel. 
Secondly, this design uses  
a bipolar pulse with a 
cathodic and anodic phase, 
which has been shown to produce a more consistent response to repeated 
stimulation than pulses of either type alone (Jensen and Rizzo, 2009). Prototype 
designs have been produced in three 
different pixel (electrode) sizes (70, 
140, and 280 μm).  
The intrinsic response 
properties of silicon make near 
infrared (NIR) light an ideal stimulus 
in terms of the responsivity of the 
array material to wavelength (Figure 
10). Essentially, this means the 
device will create more current for 
Figure 9. Scanning electron microscopy image of 
the bPVA prosthesis current generating surface 
with a magnified single pixel shown in the inset. 
Modified from Wang et al., 2012. 
Figure 10. Typical responsivity curve of 
silicon based optical sensor. The blue 
line represents the wavelength of the 
near-infrared laser and the green line 
represents the visible laser wavelength 




light in the NIR range as compared to visible light of the same intensity. The 
design of the system for patient use includes a pair of glasses mounted with a 
camera and projection system (Figure 11). The camera captures the visual scene 
and sends this information to a small pocket computer to process the image. The 
computer then sends a signal to the projector system contained within the 
glasses. With software to track eye movements, the projector generates a NIR 
image and transmits NIR light directly onto the prosthesis. In addition, this could 
allow any residual visual processing in the patient’s retina to still be utilized with 
visible light either from ambient light (possibly using a dichroic mirror) or visual 
light projected from the system. Theoretically, the two signals should add 
together to enhance visual perception.   
Experimental Goal 
The goal of these experiments was to characterize the retina-prosthesis 
interface by showing the devices provide effective, repeatable and safe 
stimulation of the retina that results in visual signals that are transmitted to a 
Figure 11. System 
design for a patient. 
The glasses contain a 
camera and 
projection system 
connected to a small 
pocket computer that 
processes the image 
before generating an 
IR image to project 
on the prosthesis. 
(Mathieson et al., 
2012) 
 23 
visual structure of the brain. The two prosthesis designs were compared to 
determine if the bPVA presents a significant improvement over the mPVA design 
in terms of spatial activation and threshold. In my experiments, 
electrophysiological recordings were used to compare the mPVA and the bPVA 
retinal prosthetic designs in terms of their ability to drive high resolution, low 
threshold responses. As in DeMarco et al., (2007), my experiments used an 
intact preparation to record responses in the SC as an indicator of the 
prosthesis/retina interface, while stimulating the prosthetic device in situ. 
   
Materials and Methods 
Animals 
 All experiments were carried out with the approval of the Institutuional 
Animal Care and Use Committee (IACUC) of the University of Louisville. The Tg 
S334ter-3 rat was used for all experiments described in this chapter (Chapter II). 
Homozygous Tg S334ter-3 rats were acquired from Dr. Matthew LaVail 
(University of California, San Francisco). Homozygous Tg S334ter-3 rats were 
generated on the albino Sprague-Dawley strain of rat. Because albinism affects 
retinal function, homozygous Tg S334ter-3 rats were bred with Long Evans 
pigmented rats to create hemizygous Tg S334ter-3 pigmented rats (one copy of 
the transgene and two normal rhodopsin genes). Hemizygous Tg S334ter-3 rats 
were the experimental animals and Long Evans rats served as normal controls 




 Experimental animals are first anesthetized with an initial cocktail of 
ketamine (85mg/kg) and xylazine (7.5 mg/kg). Once anesthetized, the pupil is 
dilated with tropicamide and phenylephrine. A suture is placed in the upper eyelid 
and traction applied to expose the superior portion of the eye. The eye is treated 
with proparacaine as a topical anesthetic and a second suture is placed in the 
superior conjunctiva near the limbus and the eye is rotated forward to expose the 
superior conjunctiva. The conjunctiva is then dissected away to expose the 
sclera. A 19-gauge vitrectomy knife is used to make a 1mm incision through the 
sclera and the retina. Ten-minutes after a retinotomy, the retina will naturally 
detach from the RPE at the retinotomy site, which creates a space to implant the 
prosthesis. The prosthetic device is then manipulated carefully into the 
retinotomy site and placement is verified with a fundus lens. Closure of the 
retinotomy site has not been necessary because adverse effects (infection, 
vitreous exudation, etc.) at the retinotomy site have not been oberved. 
 Two to four weeks after implantation, the surgical outcome was assessed 
with fundus imaging, optical coherence tomography (OCT) and fluorescein 
angiography (Figure 13). From the fundus image I determined the location of the 
prosthesis in relation to the optic nerve. OCT images were used to determine the 
general health of the retina. This technique generates perpendicular images 
through the retina can help identify problems such as edema, gliosis, or other 
trauma near the prosthetic device. The retinal vasculature is also an important 
indicator of a successful surgery and the health of the retina. Fluorescein was 
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used to illuminate vessels within the eye, after the dye is injected in the intra-
peritoneal cavity. Once in the vascular system, the dye is transported to the 
retina and illuminates the retinal vasculature for assessment. A successful 
surgery will show vasculature over the entire prosthesis as shown in Figure 12. If 
the prosthesis was not subretinal or there were conspicuous complications within 
the retina, the animal was not used for experimental purposes. 
 
Experimental Surgery 
Animals were anesthetized with the same cocktail used for the implant 
surgery. A diluted anesthesia cocktail (1:1 in ringer’s solution) was administered 
throughout the duration of the experiment via a catheter inserted into the femoral 
vein and an infusion pump. Once the catheter was in place, the animal was 
immobilized in a stereotaxic. The skin on the dorsal surface of the skull was cut 
down the midline and retracted to expose the skull surface. A micro-drill was then 
Figure 12. Fundus image 
(top), OCT image (bottom 
left), and fluorescein 
angiography (bottom right) 
of mPVA implanted Tg 
S334ter-3 rat. The prosthesis 
is clearly visible in all three 
measurements and the 
retina is in contact with the 
mPVA prosthesis based on 
the OCT image. 
Prosthesis 
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used to create a ~1.5 x 1.5 mm square craniotomy in the skull. The cortex was 
then aspirated to expose the SC surface. Custom made lacquer coated tungsten 
electrodes (0.25-2 MΩ) were used to record extra-cellular activity in either the SC 
or optic nerve.  
 
Electrophysiology 
To record and assess prosthesis-evoked activity in the SC, a similar 
design to DeMarco et al. (2007) was employed but incorporated the use of 
targeted stimulation of the prosthetic devices. A modified PASCAL 
photocoagulation laser (Topcon Medical Laser Systems) was used to direct a 
laser directly to the prosthetic device. Normally, the PASCAL system is designed 
to heat tissue within the retina to destroy portions of the retina or vasculature. 
This can be used to treat retinal detachment, diabetic retinopathy, and the wet 
form of age-related macular degeneration. In our application, the system 
provides an infrared laser (905 
nm) to stimulate the prosthetic 
device or a green laser (535 
nm) for visual stimulation, 
alignment and to precisely 
target the prosthesis. The laser 
power has been reduced from 
power levels that damage the 
retina (~300 mW/mm2 for a 
Figure 13. Spectral sensitivity of the 
UV and M cones in rats. Jacobs et al., 
2001. 
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single pulse) to innocuous levels for the retina (~2.4 to 19.1 mW/mm2). A custom 
LabView program (National Instruments Corporation) drives the laser and 
modulates the pulse width (duration) and intensity. The laser spot size can be 
adjusted to smaller or larger through the optics within the laser system itself or by 
changing the fiber optic cable that transmits the laser beam. For both prosthetic 
devices, the subretinal approach for implantation is utilized. In addition to the 
advantages of NIR light to stimulate silicon, I can be certain that any evoked 
activity with NIR light is generated through the prosthesis. Like mice, rats are 
dichromats with a medium/long (M) cone and a UV-cone (or S cone), with peak 
absorbance at 359 and 509 nm for the UV-cone and M-cone respectively (Figure 
13). The M-cone spectral sensitivity is far below the 905 nm NIR light used for 
this study. Therefore, stimulation with 905 nm NIR light will not stimulate either 
cone type. 
Multi-cellular responses were recorded from the SC using a single, 
lacquer-insulated tungsten electrode. To map the spatial extent and retinotopy of 
the prosthesis-evoked responses, the entire exposed dorsal surface of the SC 
was recorded by stepping the electrode in 200 micron steps across 54 distinct 
sites within the SC. The electrode depth was typically 150-400 microns, 
consistent with the extent of the superficial layers of the SC. Trials consisted of 
~20-25 stimulus presentations, with successful stimulation being defined as clear 





All data were collected and processed in Spike2 (Cambridge Electronic 
Designs, Cambridge, England). For statistical analyses, Prism 5.04 (Graphpad 
Software, La Jolla, CA) was used. Normally distributed data were analyzed with 
parametric statistics and a p-value<0.05 was considered significant. Unless 
noted, the data were normally distributed.  
 
Results 
Direct stimulation of either type of prosthetic device yields short latency 
responses that are transmitted to the SC via retinal synaptic input from BCs to 
RGCs 
The Tg S334ter-3 rat was used to assess the interface between both 
types of PVA and the retina. Devices were implanted at either 35 or 75 days of 
age and evaluation times post-surgery were grouped into 50-90 and 120-150 
days. An example of a prosthesis evoked response to direct IR stimulation is 
shown in Figure 14. Direct IR stimulation of the PVA produces prosthesis-evoked 
responses in 80% (n = 21/25) of mPVA implanted and in 95% (n=20/21) of bPVA 
implanted rats that were implanted successfully. This high success rate 
represents an improvement over previous work with the same device in the RCS 
RP model, where 64% (n=9/14) showed mPVA prosthesis-evoked responses. I 
believe that this is due to the use of the new PASCAL stimulation system as it 
combines the visualization of the device with direct presentation of the stimulus 
onto the prosthesis (both visible and IR). In contrast, a full field IR stimulus was 
used by Demarco et al. (2007).  
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In addition to its selectivity for IR stimuli, both mPVA and bPVA 
prosthesis-evoked responses can be distinguished from visually-evoked 
responses (with the same duration) by their significantly shorter time to peak 
(Figure 15A; 53 and 43 ms vs. 176 ms). The responses evoked by the prosthetic 
devices also had a significantly shorter duration than the visible stimulus of the 
same pulse duration. The bPVA-evoked responses were slower to peak and had 
a longer duration compared to mPVA-evoked responses (Figure 15B). A shorter 
onset latency for PVA evoked responses is consistent with the idea that 
responses are transferred through one less synapse (photoreceptor to BC) 
compared to visually evoked responses. The integration time of light adapted 
photoreceptors is ~ 40 ms (McNaughton, 1990), partially accounting for the 
difference in time to peak. When added with the transmission time of 
approximately 100 ms from BC transmission to RGC response (Baylor and 
Fettiplace, 1977), these estimates suggest that the devices stimulate BCs 
directly. To address this question, synaptic blockers were used to prevent 
synaptic signaling within the retina. If the PVA-evoked responses are transmitted 
Figure 14. Raster plots 
and post-stimulus 
time histogram of 
prosthesis-evoked 
responses. The 
stimulus is pulsed at 
time 0 with 0.5 
seconds shown before 
and 0.75 s shown after 
the pulse. 



















through the retinal circuitry, it would be expected that synaptic blockers would 
eliminate PVA-evoked responses. If responses are present, it would indicate that 
the PVA is acting directly on RGCs. 
 
In four rats, an SC location with a robust prosthetic-evoked response was 
selected for the synaptic blocker injection. While recording the spontaneous 
activity, 2.5 μl of saline was injected into the vitreous chamber. Injections of 
saline did not reduce the spontaneous activity or eliminate implant evoked 
responses in the SC (Figure 16A, B, D). Five minutes after the saline injection, 
an injection of 2.5 μl containing a cocktail of synaptic blockers (10 μM strychnine, 
Figure 15. PVA-evoked responses respond with a shorter latency and duration 
than visually-evoked responses in the same animals. A – A comparison of the 
implant evoked responses (black trace) with the visually evoked response (blue trace) 
from a bPVA (left) and an mPVA (right). In each case the stimulus duration was 4ms. 
B – A quantitative comparison of two aspects of the evoked response shows that 
implant evoked responses are significantly faster to peak and shorter duration 
compared to visually evoked response.  * p<0.05, **p<0.01, ***p<0.001   
A. 
B. 
n=12 n=18 n=17 n=12 n=18 n=17 
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10 μM picrotoxin, 50 μM TPMPA, 50 μM D-AP5, and 10 μM CNQX) was made. 
When the blockers were present synaptic activity was largely eliminated and 
bPVA-evoked responses were no longer elicited (Figure 16C, D). The effect of 
the synaptic blockers was verified with a steady decline in spontaneous activity, 
which was usually evident within 3-5 min after injection. These results indicate 
that the prosthetic directly stimulates cells in the INL and not RGCs directly. 
 
Given that the responses are network dependent, the additional reduction in time 
to peak of the IR-evoked responses is likely due to direct depolarization of the 
BC, thereby bypassing the PR-BC signalling cascade. The light-evoked time to 
Figure 16.  The bPVA response in the SC requires synaptic transmission of the signal 
through the inner retinal circuit. A. Representative averaged response and raster plot 
of bPVA evoked response. B. Injection of 2.5 µl of saline did not significantly alter the 
bPVA-evoked response or spontaneous activity in the same animal. C. Injection of the 
synaptic blocker cocktail (2.5 µl total volume) eliminated all bPVA-evoked responses. 





peak response in WT rat BCs is ~80 ms for ON BCs, ~100ms for OFF BCs, and 
~175ms in rod BCs (Euler and Masland, 2000). In normal signalling, glutamate 
binding opens iGluRs directly in OFF BCs while in ON BCs, a reduction in 
glutamate binding inhibits a G-protein coupled cascade that normally closes the 
TRPM1 channel. These signaling processes act to depolarize BCs and open 
voltage gated calcium channels at the BC axon terminals. The increase in intra-
cellular calcium causes the release of vesicles from the axon terminal. These 
channel gated and G-protein related processes in the BC dendrites are likely to 
be bypassed when stimulated by a PVA. The latency, therefore, would be limited 
to the time for calcium entry into the BC terminals, vessicular release, 
neurotransmitter diffusion across the BC to RGC synapse, and depolarization of 
the RGC.  
In addition, Sekirnjak et al. (2008) reported direct activation of RGCs in 
monkey retina resulted in sub-millisecond latency to response. In no experiment 
did I record responses in the SC with a latency that was less than 35 
milliseconds. Taken together, the above data strongly support my hypothesis that 
the bPVA devices stimulate the retinal network rather than RGCs directly. 
 
Direct stimulation of the prosthetic device yields responses in a location generally 
matched to the position of the implant in the retina. 
Since the SC forms a retinotopic map, the IR-evoked responses should 
correlate with the location of the device in the eye. Without a predictable 
relationship between the location of the prosthetic and the area of the retina 
stimulated, spatial information would not be reliably relayed to the patient. To 
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address whether or not the predicted location of stimulation matched the 
observed location of stimulation, fundus images for each implanted rat were 
taken, which included the optic nerve head (ONH) and the device. The location of 
the device relative to the ONH along the vertical and horizontal meridians were 
computed and compared to the sites of evoked activity on the SC retinotopic 
map. Figure 17 shows representative images of the fundus of two rats implanted 
with an mPVA (top) and a bPVA (bottom). The corresponding PVA evoked 
responses are plotted on the right as a heat map of the dorsal surface of the SC. 
Responsive areas appear as colors, where red represents the strongest 
excitatory responses and blue the weakest responses. Black areas indicate 
locations in the SC where prosthetic evoked responses were not elicited. I 
compared the location of PVA evoked responses recorded in the SC  
to their expected location based on implant placement in the eye. The fundus 
image was used to compute an estimate of the expected location of PVA 
influence in the SC. To do this, I first measure the distance to the center of the 
device from the center of the optic nerve head along the vertical (superior-
inferior) and horizontal (temporal-nasal) axes (Figure 18A). These two distances 
are converted to visual degrees where 59 μm subtends 1o of visual angle in the 
rat eye (Siminoff et al., 1966). These estimates are then compared to the location 
of the peak PVA-evoked responses in the SC using an image adapted from 
Siminoff et al. (1966, Figure 18B). Each line on the SC map in Figure 18B 
represents 10 degrees and the optic nerve has a defined position. Using the 
fundus image estimates, the difference between the two locations was calculated 
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along each axis. For reference, the bPVA device is 1.2x0.8 mm which 
corresponds to 20x13.5 degrees of visual angle. 
 
 
Figure 17. Representative 
fundus images and 
corresponding SC activity 
maps. The top fundus image 
and map show a localized 
region with prosthesis-evoked 
responses. Stronger 
responses are in red and 
weaker responses in blue. 
Black represents 
unresponsive locations. ONH 






ONH 0.5 mm 
0.5 mm 
bPVA 




Figure 19A plots the predicted location of the PVA as a function of the location of 
its actual evoked activity. Each arrow represents one animal and the length of the 
arrow represents the change between predicted location (blue dot) and the actual 
center of the recorded activity in the SC (red arrow head). The rat retina covers 
approximately 140 degrees along the T-N axis and 130 degress across the S-I 
axis (Siminoff et al 1966). Figure 19B plots a summary of the deviations from the 
predicted location for all rats. On this graph, a perfect match between predicted 
and actual is represented by the green circle at the origin (0,0). Given the size of 
the retinal representation, the differences I observed are fairly restricted. 
However, there is a trend, in 22 out of 23 rats the predicted location is superior  
to the actual area of activity. Additionally, in 16 out of 23 rats the predicted 
location is nasal to the actual area of activity. Given the consistency of the 
direction of difference, it most likely indicates a consistent error in one of our 
Figure 18. A. Fundus image showing the size of the implant in visual degrees and the 
distance from the optic nerve along both the S-I and T-N axis. B. For the animal shown in 
A, the deviation of the SC recorded activity from the predicted location is plotted on the 
dorsal surface of the SC. Each line on the SC map represents ten visual degrees. 
A B 
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estimates of location on the SC surface due to errors of electrode placement 
(discussed below) or differences in the visual map with the estimates of Siminoff 
et al., 1966. In addition, there is the possibility that the implant could have 
changed location in the time between imaging the fundus and 
electrophysiological assessment (2-4 weeks). 
 
Measurement errors were introduced due to the way I estimated the 
location of the device based the fundus image and also due to the recording 
protocol. The device itself covers up to 20o, but the fundus measurement was 
taken to the center of the device. This introduces an error of up to 10o due to the 
size of the device as the recorded activity was not necessarily from the center of 
the device. Current spread at the edges of the prosthesis also makes the device 
functionally slightly larger than its physical size by ~200 μm (3.5 o) at each edge 
(unpublished obervations by our collaborators). Our estimates of SC location 
Figure 19.  A. SC representation of each animal’s predicted vs. actual location 
of PVA influence.  B. The deviation from the predicted location. Perfect 
correlation between the predicted and actual area of PVA influence in the SC 
would be at the origin (0,0).   
A. B. 
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may contribute as a result of anatomic variation. Blood vessels on the surface of 
the SC are used as a reference for placement of the first recording site, but there 
can be substantial anatomical variation from animal to animal. When all sources 
of error are considered, I compute a potential error of 30o, 18 out of 23 locations 
fall within this predicted error range. Data points outside of this margin of error 
may indicate an implant interface directly with RGCs and their axons crossing 
under the PVA. This would create large deviations from the predicted location. 
Alternatiely, devices may have physically shifted more in these animals over 
time. Because there were so few of these animals and the calculations were 
made after experiments, I did not test the idea that RGCs were directly 
stimulated in these animals.  
 
Implantation age and duration have no significant effect on thresholds for mPVA 
evoked responses 
 The threshold for stimulation is a concern with implant devices, as too 
much current can cause damage to both the retina and the device. Further, there 
could be differences in the interface between the implant and the degenerating 
retina as photoreceptor death proceeds. To examine these questions, I 
compared thresholds in two groups of Tg S334ter-3 rats implanted at different 
stages of degeneration, ~P35 and ~P75. I also varied the time between 
implantation and evaluation in both implantation age groups: 120-150 days post 
implantation. At P35 there are 3-5 rows of nuclei left in the ONL while P75 
animals only have 1-2 rows of nuclei remaining, responding exclusively to 
 38 
photopic stimuli. Figure 20 compares the threshold responses across 
implantation age (A) and duration (B). The data show that neither implantation 
age nor duration have a significant effect on threshold, consistent with data 
reported by Chan et al (2011).  
 
Threshold for stimulation is not different across pixel sizes in bPVA devices but 
bPVA devices have a significantly higher threshold than mPVA devices. 
Theoretically, reducing pixel size and increasing density will increase 
visual spatial resolution. However, pixel size affects current density which can 
affect lateral current spread. To compare the effect of pixel size on threshold, 
three groups of animals were implanted with small (70 μm), medium (140 μm), or 
large (280 μm) pixel bPVA devices. Figure 21 compares the threshold responses 
across pixel size within bPVA devices (A) and between mPVA and bPVA devices 
(B). The data show that pixel size did not significantly influence threshold for 
bPVA devices. Figure 21A shows the comparison across pixel size with all 
Figure 20. The figures plot the minimum intensity required to elicit a response 
at a particular pulse duration.  A. Implantation age had no effect on thresholds 
for stimulation. B. Implantation duration also did not affect stimulation 
thresholds. Note all thresholds are at least 1.5 log units below safety limits 
(dashed line) for the retina. 
A B 
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having similar thresholds. When compared to mPVA devices however, bPVAs 
have a consistently higher threshold. This is probably a function of their smaller 
current spread, which is more spatially limited than the bPVA device. The current 
generated by smaller electrodes will not spread as far, requiring either a closer 
interface between the electrode and the tissue to be stimulated or for the 
electrode to produce more current (Palanker et al., 2005). Thus, higher threshold 
in bPVAs is consistent with expectations. It is important to note that all thresholds 
are well below the defined safetly limit for these devices in the retina.  
 
 
PVA-evoked responses have a linear range as a function of pulse duration 
The interaction between the retina and a prosthetic device is certain to 
shape the perception for a patient. In the intact retina, the output of the 
photoreceptor is proportional to the intensity of the light within a given adaptation 
range. Similarly, it is ideal if the amount of current produced by the implant is 
Figure 21. Device thresholds are well below the safety limits. A. The intensity-
duration plot comparing bPVA pixel sizes.  Medium and large pixels were not 
significantly different from one another. B. Comparison between small bPVA, 
combined medium and large bPVA, and mPVA device thresholds. mPVA thresholds 
were similar to the medium/large bPVA devices but small bPVA devices had a 
significantly higher threshold than the mPVA device thresholds. (Kruskal-Wallis). 
***P<0.001, ****p<0.0001 
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proportional to the intensity of the IR stimulus. In this way, larger portions of the 
retina or cells with higher threshold may be recruited when the device is driven 
harder to increase the current output of the device. In addition, the response 
limits of the retina are important to quantify in order to keep the stimulus intensity 
as low as possible (to prevent damage to the tissue) while eliciting consistent 
responses.  
 
To determine if the peak SC response changes as a function of pulse 
duration, I recorded from the SC while modulating the pulse duration. Figure 22 
plots these data and demonstrates a linear relationship between response and 
pulse duration between 0.25  and 2 ms with saturation at durations above 2 ms. 
This relationship was the same for both bPBA and mPVA devices and there was 
no significant difference between device types. 
 
Figure 22. Normalized response as a function of pulse duration. Compared to 
the 10 ms response, both mPVA and bPVA devices show a linear range 
between 0.25 and 2 ms. Beyond 2 ms, the response does not significantly 










bPVA devices provide focal activation of the retina that is not seen with mPVA 
devices 
 At present there are devices that are being tested in human RP patients 
(Humayun et al., 2010). These implants have a limited number of electrodes with 
relatively wide spacing. While preliminary reports are promising,  most patients 
can only use the device for simple pattern vision or luminance levels. However, 
the ultimate goal is to provide high spatial and temporal resolution vision to 
patients that have lost photoreceptors. To test the hypothesis that the bPVA 
design should activate the retina in a focal manner with increased spatial 
resolution over the mPVA, I measured the spatial resolution of mPVA (n=12) and  
bPVA (n=14) devices in implanted animals. An 
SC site with a robust PVA-evoked response was 
selected and the response at this site was 
recorded as a small diameter spot stimulus (0.5 
mm) was systematically moved to one of five 
sites on the PVA. Figure 23 depicts the regions 
stimulated under this paradigm. Comparisons 
were made with the IR stimulus located in either 
the center or in one of four quadrants of the PVA. 
The comparison was made to determine if the 
response would increase or decrease depending 
on what region of the device was stimulated. 





Figure 23.  Diagram 
showing the five different 
stimulus locations for each 
device type.  The larger 
circle represents an mPVA 
and the entire rectangle a 
bPVA.  
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stimulating the device in different regions should shift the area of response in the 
SC to match the region of the retina that is stimulated. In this way, recording at 
one SC site while moving the IR stimulus should reduce or increase the reponse 
recorded in the SC. If the response does not change, the entire device is 
stimulating regions of the retina that are larger than the stimulus. In this scenario, 
the entire device is functionally a single pixel, rendering the electrode array 
ineffective for any spatial resolution. Figure 24 plots representative 
 
responses for an mPVA (A) and a bPVA (B) device. The responses evoked by 
spots across mPVA devices were similar in 14/17 animals (Figure 25), indicating 
little or no spatial resolution. In contrast, bPVA devices showed significant 
response change as a function of spot location in 22/23 animals, where the 
response at each region was compared to the largest response region across the 
device. I believe that the best explanation for response modulation in the 3/17 
mPVA is a poor interface between the prosthesis and the retina in one quadrant 
Figure 24.  A. Histogram showing an example of the unmodulated 
response typical of mPVA devices. B. Example of a significantly 
modulated response from a bPVA implanted animal.   
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of the device. In these devices, the 
quadrant with smaller responses may not 
have been as closely juxtaposed to the 
retina, resulitng in one region with a 
significanly smaller response. These 
results strongly support the idea that 
current generated by bPVA devices is 
able to flow locally because of the 
individual return electrodes.  This also 
strongly supports the bPVA design as a 
significant improvement over older prosthetics. 
 
Discussion 
 In comparing the mPVA and bPVA devices, my results demonstrate that 
the bPVA design is a significant improvement in prosthetic device design. The 
primary improvement is its superior spatial localization, while continuing to 
achieve low thresholds for activation that are far below established safety limits 
for the retina. The high integration success with the bPVA devices indicates a 
better interaction between the device and the retina than the older mPVA device. 
This is likely due to the targeted stimulus but may also result from the increased 
flexibility of the bPVA design. Jensen and Rizzo (2009) concluded that a biphasic 
pulse was the most consistent stimulus to use in the rd1 mouse model of RP and 
my results with a higher success rate using bPVA devices support their 
Figure 25. Overall, only 1 bPVA 
device did not show some 
modulation while only 3 of 17 
mPVA devices showed any 
modulation when moving the 
stimulus location across the face 
of the PVA. 
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conclusion. It was very evident that surgical implantation technique is paramount 
to a successful interface of the device with the retina. All animals without a clear 
interface between the device and the retina (OCT images) had no prosthesis 
evoked responses.  
As manufacturing technology becomes more advanced, the size of the 
electrodes will undoubtedly decrese to theoretically provide increasingly focal 
stimulation of the retina. While it is important to increase the resolution of the 
devices and the perceived image, the safety of the retina must be considered as 
well. There was a trend for an increase in threshold in the smallest size pixel in 
the bPVA devices (70 μm). In addition, there was a significant increase in 
thresholds for bPVA devices when compared to mPVA devices. While still far 
below safety limits, the challenge for new devices in the future will be a balance 
between the size of the electrodes and approaching safety limits. Any increase in 
risk to the patient or to the lifetime of the device must be carefully considered 
when attempting to improve the design of prosthetic devices.  
It should be noted that other approaches also are being actively explored 
for the replacement of degenerated photoreceptors. For example, of great 
potential for restoration of vision for patients with degenerative disease is the 
transplantation of stem or other progenitor cells into the retina (Schmeer et al., 
2012). The current state of this potential treatment is far behind retinal 
prosthetics. Early clinical trials using stem cells are currently under way though 
some trials ended prematurely due to safety concerns. In contrast, the FDA 
recently approved the first prosthetic device for use in humans. Second Sight 
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Medical Products Inc. received approval for general use of their 60 electrode 
Argus II device in end stage RP patients in the US. Additionally, the state of the 
retina for stem cells or transplants may preclude patients with severely 
degenerated retinas. It has been shown that there are significant morphological 
and structural changes that take place in advanced stage human RP patients 
and animal models (Marc and Jones, 2003). In addition, the expression of 
mGluR6 receptors in the BCs has been shown to decline in multiple models of 
RP, including rd1 and 10 mice (Stasheff 2008, Puthussary et al., 2009; 
respectively) and RCS rat (Pu et al., 2006) while the expression of iGluR on OFF 
BCs is stable even after the loss of all visual signaling. If the retina can no longer 
respond to glutamate signaling, implantation of photoreceptors would be 
ineffective at these stages of degeneration the retina, even if synapses form 
between the stem cells and BCs. If this loss of glutamate receptors is evident in 
human RP patients as well, the best treatment option may be retinal prosthetic 
devices. In addition, embryonic stem cells require immune-suppressive therapy 
for the life of the patient, something that is not required with prosthetic devices. 
This is not a trivial matter as major health complications can arise when the 
immune system is suppressed.  
The wide-spread use of retinal prosthetic devices is still in the beginning 
stages and many questions remain unanswered. Will retinal adaptation to 
electrical stimulation result in higher thresholds for activation over time? There is 
evidence for short-term adaptation on the order of seconds (Freeman and Fried, 
2011) but long-term stability of thresholds in humans has not been definitively 
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established. In many cases, the first response to PVA-stimulation did appear to 
be larger but this was not quantified. This analysis will be addressed in the future.  
There is debate about what the most physiologically relevant stimulus is to 
the retina. It has been shown that rabbit RGCs can follow pulse trains up to 600 
Hz when stimulated directly using tungsten electrodes (Cai et al., 2011) but 
normal human frequency limits are in the range of 45 Hz. Does the stimulus have 
to transmit signals that are close to what is processed normally or will plasticity 
within the visual system enable it to adapt to this new information and interpret it 
as normal (or potentially supernormal) perceptions? Can a stimulation 
configuration be found to differentially stimulate specific cell sub-types to 
generate both ON and OFF signals? BCs are the point at which the ON and OFF 
pathways diverge, so stimulating all BC types at the same time may result in 
conflicting signals. On the other hand, there is evidence in the literature that 
patients with complete congenital stationary night blindness, where the retina 
lacks signaling through the ON pathway, have relatively normal day vision 
(Bijveld et al., 2013). Therefore, it is possible that the device does not require 
dual pathway signaling to provide normal vision.  
Regardless of the answers to these questions, there is no doubt that 
retinal prosthetic devices integrate with the degenerate retina and generate 
signals that can be detected outside of the retina and can be used to represent 
some properties of the visual environment, in patients with photoreceptor 
degeneration. While the current visual acuity achieved with prosthetic devices in 
my studies as well as in work with human patients may be low (20/560 Zrenner et 
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al., 2012 and 20/1260 with Argus II system, Humayun et al., 2012), this can still 
represent a life changing treatment. Many patients involved in clinical trials were 
late stage patients with little more than light or dark perception if any perception 
at all. The potential of these devices to provide independence for a profoundly 
blind patient cannot be understated. To have form, contrast, and/or depth 
perception again may allow them to navigate a room without bumping into 
objects, cross the street safely, or cook a meal easily; all things those with 












FUNCTIONAL ASSESSMENT OF TWO MODELS OF 
RETINITIS PIGMENTOSA INDICATE A PREFERENTIAL 




 In many cases, patients with degenerative diseases of the retina do not 
present with symptoms until very late in the progression of the disease. Often the 
loss of vision is what drives patients to see a physician. Unfortunately, during the 
degenerative process within the photoreceptor layer, the rest of the retina is not 
static. Morphologically, there are numerous reports that show anatomical 
reorganization, but changes in function at the level of the RGCs have not been 
well studied. To better understand what treatments may be most effective, a 
description of these changes is needed. If early functional changes are found, 
this could facilitate early therapeutic intervention and may lead to new early 
screening procedures, all of which may lead to a better prognosis for patients 
with degenerative diseases. 
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 Reactive Changes During Degeneration 
 Morphologic changes that occur during the degenerative process have 
been described previously. In rat and mouse models of RP, a combination of glial 
migration, vascular and RPE invasion, receptor expression changes, aberrant 
connections, and other changes have been described (Marc and Jones, 2003, 
Cuenca et al., 2004). Changes within the INL include neurite sprouting in 
horizontal cells, retraction of BC dendrites, and decreased mGluR6 staining 
(Strettoi et al., 2002). Aberrant connections form between rod BCs and cones in 
late stages of degeneration though it is not known if the synapses are functional 
(Marc and Jones, 2003, Cuenca et al., 2004).  
In addition to structural changes, some morphological and functional 
changes have been reported. In the rd1 mouse, mGluR6 receptor expression on 
the BC dendritic tips is lost early in the degenerative process, while iGluR 
receptors (the OFF pathway) have been reported to persist and respond in vitro 
to AMPA/Kainate (iGluR agonists) puffs long after photoreceptors are lost 
(Stasheff, 2008). Functionally, the loss of RGCs with ON responses and the 
retention of RGCs with OFF responses have also been reported in the rd10 
mouse (Puthessary et al., 2009, Stasheff et al., 2011) and the RCS rat (Pu et al 
2006). The question remains, however, if this is something inherent to the 
degenerative process in general or if it is a result of a subset of specific 
mutations. The three examples listed above represent a mutation in rod 
photoreceptors (Pde6 gene) for the rd1 and rd10 mice and a mutation in the RPE 
(Mertk gene) for the RCS rat, suggesting this may be common to RP. However, 
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Sekirnjak et al. (2011) reported that there was no differential loss of ON vs. OFF 
responses in the Tg P23H-1 rat. They did find, however, that in the spontaneous 
firing rate of their OFF RGCs was elevated, while ON RGC firing rate declined. In 
both types of RGCs, receptive field size reduced with age, indicating a reduction 
in excitatory input. Importantly though, all RGCs were responsive to direct 
electrical stimulation even after light stimuli could no longer evoke a response 
(Sekirnjak et al 2009). 
 
Increased Spontaneous Activity and Rhythmic Bursting 
Many models of retinal dysfunction exhibit characteristic bursting in their 
spontaneous activity that is rhythmic. In the rd1 mouse, bursts of activity at ~10 
Hz were found in both ON and OFF RGCs, but the morphology and dendritic 
stratification of these RGCs remained unaltered (Margolis et al 2008). This 
characteristic bursting activity has been described in other retinal mutants as 
well, including the nob mouse (Demas et al., 2006), Tg P23H-1 rat (Sekirnjak et 
al., 2009), and RCS rat (Sauve et al., 2001) among others. This suggests there 
are common functional changes within the retina when normal signaling 
pathways to RGCs are lost. If a common mechanism exists for changes in 
spontaneous activity, it is possible that there are other common functional 






 The goal of these experiments was to describe some of the functional 
changes that are associated with the degenerative process. Responses were 
recorded from the SC in Tg rats and compared to age matched WT animals. 
Most previous research has focused on morphological changes within the retina 
but the functional changes have been explored to a lesser extent. To replace lost 
photoreceptors, either functionally or with cellular transplants, the remaining 
retina must be able to transmit signals. A description of functional changes will 
help guide future research and help determine the limits of proposed treatments. 
An in vivo preparation was used to determine what signals are transmitted to the 
SC from the retina as photoreceptors are lost. 
 
Materials and Methods 
Animals 
 Three rat strains were used for all experiments. The Long Evans strain 
(Charles River Labs) was used as the control for all experiments and exhibits 
normal retinal function and morphology. Homozygous Tg P23H-1 and Tg 
S334ter-3 rats were acquired from Dr. Matthew LaVail at the University of 
California, San Francisco, CA. Homozygous animals for both models are albino 
as the Sprague-Dawley rat was used as the background strain. In order to 
circumvent effects of albinism, homozygous Tg animals were bred with Long 
Evans rats to create hemizygous Tg pigmented animals with one copy of the 
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transgene and two normal rat rhodopsin genes. Hemizygous Tg animals are 
used in all experiments. 
 
In Vivo Experimental Surgery 
 The animal is first anesthetized with a cocktail of anesthesia consisting of 
ketamine and xylazine administered at a dose of ~105 and 7.5 mg/kg 
respectively. Once deeply anesthetized, a custom catheter is surgically placed in 
the femoral vein to administer a booster cocktail at half the original concentration. 
The catheter is attached to a syringe pump to keep the animal at a constant 
plane of anesthesia for the duration of the experiment. Once the catheter is in 
place, the animal is placed in a stereotaxis (David Kopf Instruments) to 
immobilize the head. The skin over the skull is retracted by making a 1 inch 
incision down the midline. Any connective tissue is teased away from the skull to 
expose the sutures. Using the labdoidal, coronal and sagittal sutures as 
landmarks, a micro drill (Fine Science Tools, Heidelberg, Germany) is used to 
make an approximately 1x1 cm opening in the skull. The dura is removed 
carefully and once exposed, the surface of the brain is vacuum aspirated to 







In Vivo Electrophysiology 
 Once the surface of the SC is exposed, a custom made lacquer coated 
tungsten electrode (0.25-2 MΩ) is used to record extra-cellular activity in the SC. 
The margins of the SC are estimated based on large blood vessels that border 
the edges. The electrode is positioned over the first SC site using a set of 
manipulators (David Kopf Instruments) along the X and Y axis. Once in place, a 
hydraulic microdrive (David Kopf Instruments) is used to lower the electrode to 
the proper depth at a rate of 25 µm per second. The best recorded responses 
were at a depth range between 150 and 400 microns. A clear bursting activity 
was heard if the electrode was lowered beyond this range, indicating the 
electrode had passed through the superficial visual layers of the SC. Data was 
sampled at 54 sites encompassing the entire exposed surface of the SC. The 
space between two adjacent sites is 
approximately 200 µm (Figure 26). 
Full field stimulation with a peak 
wavelength of 470 nm was presented 
using a hemi-field dome in a dim 
room. The stimulus intensity, duration 
(2s), and inter-stimulus interval (10s) 
was controlled using custom programs 
in LabView (National Instruments, 
Austin, TX). Signals were amplified 
through an XCell-3 Microelectrode 
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Figure 26. The 54 sites 
sampled across the dorsal 
surface of the SC.   
 54 
Amplifier (FHC, Bowdoin, ME) and sampled at 10 KHz using a Power1401 data 
acquisition unit (Cambridge Electronic Design, Cambridge, England). Data was 
collected and stored on a computer running Spike2 software (Cambridge 
Electronic Design, Cambridge, England). 
 
In Vivo Data Analysis 
Data was later analyzed offline using custom scripts in Spike2. Briefly, a 
threshold was set at 3.5 standard deviations above the average noise 
(spontaneous activity) levels and this was used to define the response (or lack 
of). The raw data was converted to a wave form based on the rate histogram 
(Figure 27). This wave form was then averaged across the ~20 trials and then 
analyzed for response parameters, including response area, amplitude, time to 
peak, and response duration. This was further broken down to the ON response 
and OFF response as the long 2s stimulus allows the two responses to be clearly 
distinguished. Once the response parameters were quantified, statistical analysis 




In Vitro Preparation 
 For multi-electrode array (MEA) recordings, animals were dark adapted for 
at least 1 hour prior to recording. Using infra-red goggles, animals were 
anesthetized with the same cocktail of ketamine and xylazine. Once deeply 
anesthetized, the animal was sacrificed via thoracotomy and the eyes 
enucleated. Under dim red light, the cornea and lens were removed and the 
retina dissected from the eye cup. The retina was then laid RGC side up and 
rinsed with oxygenated bicarbonate buffered Ringer’s solution. A mixture of 
collagenase and hyaluronidase was then placed on the retina for 15 minutes to 
remove the vitreous. The retina was then rinsed three times, any remaining 
vitreous removed with fine forceps, and then quartered. One quarter was placed 
photoreceptor side against a culture membrane and then transferred to the 
recording chamber where it was placed RGC side against the electrodes. A 
Figure 27.  A. Example raw SC response 
trace. B. PSTH generated from the raw trace.  
C. Wave form converted from the PSTH in B. 
The response is defined as the time at which 
the trace crosses threshold (blue line in C.) 
to the time it dips back below threshold. 
Threshold is defined as 3.5 standard 
deviations above the spontaneous activity. 









platinum ring was then placed on top of the membrane but not the retina, so not 
to occlude any visual stimulus from the retina. 
 
In Vitro Electrophysiology 
 The MEA (Multi-Channel Systems, Reutlingen, Germany) consists of a 
glass chamber with 60 platinum-iridium electrodes lining the bottom of the 
chamber. Each electrode is 30 µm in diameter and the inter-electrode distance is 
200 µm. Each electrode records extracellular spiking activity from the RGCs. 
Data is sampled at 10 kHz and recorded with a MEA1060 system from Multi-
Channel Systems. The same full-field stimulus (470 nm, duration, intensity, isi, 
etc.) used for the in vivo experiments was used for these experiments. The data 
was collected using MC_Rack software (Multi-Channel Systems), band pass 
filtered between 80 and 3000 Hz and spikes were sorted into individual units 
manually using Offline Sorter (Plexon, Inc., Dallas, TX). Individual units with an 
amplitude less than ~40 µV were not used. Data was then analyzed using 
Neuroexplorer (Plexon, Inc., Dallas, TX).  
 
ON-OFF Index 
 To compare the ON-OFF ratio between groups, an ON-OFF index value 
was calculated. This was done to normalize the data for comparison and ensure 
that the absolute values were not artificially creating differences between groups 
due to an experimental setup difference over time as this study was dependent 
on large age differences between animals, and hence long times between 
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recording different groups. This value is calculated as follows; the OFF 
component is subtracted from the ON component and this is then divided by the 




This results in a possible range from 1 to -1, where 1 represents a completely ON 
dominated response, -1 represents a completely OFF dominated response and 0 
would be equal responses between the two components. 
 
Results 
As photoreceptors are lost, there is a shift from ON to OFF dominated SC 
responses in Tg P23H-1 rats 
I recorded the visual responses in the SC of control rats as they aged (50 
to 300 days). In the SC, responses to a 2s stimulus evoked a response at both 
light onset and at light offset. In control rats, SC responses show both an ON and 
OFF response to visual stimuli with a slightly larger ON response on average. 
This response profile does not change with age in WT rats. As no changes were 
seen in WT rats, in all of the comparisons with Tg rats, WT data were combined 
into one control group.  
Consistent with morphological observations (Kolomiets et al., 2010), the 
cone-driven visual responses in hemizygous Tg P23H-1 RGCs declined with age 
up to ~P550 (Sekirnjak et al., 2009). My data also show visually evoked 
responses in the SC through P300 in hemizygous Tg P23H-1 rats, my oldest 
 58 
group evaluated. In addition to the overall loss of visual function, I found a 
surprising change in the balance between the ON-OFF responses in the SC in 
Tg P23H-1 rats when compared to WT. In Tg P23H-1 animals up to ~P90, SC 
responses are balanced between ON and OFF and are relatively similar to WT. 
From ~P120 the Tg P23H-1 responses in the SC shifted towards OFF dominated 
and the shift became more pronounced with age and progression of 
photoreceptor degeneration (Figure 28). This finding had not been previously 
reported in this RP model; in fact a lack of change has been reported (Sekirnjak 
et al., 2009). At approximately P300, where the total ON response has decline to 
~25% of WT, Tg P23H-1 SC responses are strongly OFF-dominated and the 
OFF response has increased to ~250% over the WT OFF response (Figure 29). 
The total response depends on both response amplitude and duration, and 
changes in either of these parameters could cause this overall response change. 
I examined both of these parameters and Figure 30 plots the changes in duration 










A: Typical visually-evoked response in the SC of a WT rat.   
B: Typical visually evoked response in the SC of P300 Tg P23H-1 rats.  The 
white bar beneath each PSTH represents the duration of the visible 
stimulus.  There is a large On response and a smaller Off response in WT 
SC. In contrast, the response in P300 Tg P23H rats shows a strongly Off-
dominated response that has developed with age. 
  
Figure 29.  Comparison of the On and Off total SC response in Tg P23H-1 rats 
as they age compared to WT rats.  No age related changes were seen in WT 
rats, therefore all WT animals were grouped for this comparison. *p <0.05, 
**p<0.01, ***p<0.001, ****p<0.0001. WT n=13, Tg P23H-1 n=6 for each group 
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The results suggest that the loss of the ON response is due mainly to a loss of 
response duration. In contrast, the increase in the OFF response is driven by an 
increase in response amplitude. This indicates that the ON pathway input to the 
SC initially becomes more transient and then loses overall excitatory input or 
there is a change in the SC circuitry as a result of a loss of excitatory input from 
the retina. The OFF response peak amplitude significantly increases, which is 
A. 
B. 
Figure 30. A. ON and OFF response duration in WT vs. Tg P23H-1 rats as 
they age. B. ON and OFF response amplitude in WT vs. Tg P23H-1 rats as 
they age. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. WT n=13 Tg P23H-1 n=6 
per group 
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most likely to result from a loss of tonic inhibition from the declining ON pathway 
either at the level of the retinal input or within the SC circuit.   
 
OFF dominated SC responses arise early and do not change in Tg S334ter-3 
rats 
When compared to the Tg P23H-1 rat, the Tg S334ter-3 mutation results 
in a much faster degeneration of photoreceptors. This includes a decline in both 
rod and cone driven responses in the SC. The functional consequences of this 
degeneration were equally rapid. In Tg S334ter-3 rats, SC responses were 
already OFF dominated at the youngest age I recorded, P25 (Figure 31; Note: it 
is very difficult to record from rats younger than P25 in vivo). This difference 
between the two models is clearly evident with the aggressive degeneration 
present in the Tg S334ter-3 model. 
 
Similar to previous publications, I found that by ~P180, all visual responses in the 
SC are lost. There also were no significant changes in the ON or OFF response 
Figure 31.  Comparison of the ON and OFF total SC response in Tg 
S334ter-3 rats.  In contrast to the Tg P23H-1 rats, there were no age related 
changes in the Tg S334ter-3 rats. *p<0.05, **p<0.01, ***p<0.001, 
****P<0.0001 
n=13 





characteristics as the animals aged in contrast to Tg P23H-1 rats. While the OFF 
response increased in Tg P23H-1 rats, this was not the case in Tg S334ter-3 
rats. The OFF response was not significantly different from WT in Tg S334ter-3 
rats at any age. Combined with the lack of change in the ON pathway with age, 
this may indicate a sort of functional steady state within the retina until all visual 
responses are lost. In addition, this may mean only neurons within the ON 
pathway need to be targeted for treatment, while both the ON and OFF pathway 
in Tg P23H-1 rats may need to be treated to address their respective changes. 
Figure 32 plots the ON-OFF index values for the Tg S334ter-3 groups. When 
compared to the profile of the Tg P23H-1, Tg S334ter-3 rats have a similar profile 






Figure 32. The ON-
OFF index for Tg 
S334ter-3 rats shows 
strongly OFF 
dominated 
responses, similar to 
P33 Tg P23H-1 rats 
but does not change 
as a function of age. 
****p<0.0001 
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The loss of ON responses is not specific to the SC as Tg P23H-1 rat retina 
shows the loss of ON responses in vitro 
 To determine if the shift towards OFF dominated responses can be the 
consequence of changes in the input to the SC, I evaluated the spontaneous and 
visually evoked responses in Tg P23H-1 rat RGCs using an MEA in vitro. MEA 
recordings were made from both WT and from Tg P23H-1 RGCs at P35 and 
P300. Only 60% of the RGCs in the P300 Tg P23H-1 were visually responsive 
compared to 96.8% and 98.7% for P35 Tg P23H-1 and WT rats respectively. In 
WT rats, the RGC profile is 37% ON RGCs, 41% OFF, and 21% ON-OFF RGCs. 
Only one RGC (2%) was unresponsive to visual stimuli in WT rat retina. The P35 
Tg P23H-1 retinas showed a similar RGC response profile; there were relatively 
equal proportions of ON (37%) and OFF RGCs (36%), a smaller proportion of 
ON/OFF RGCs (25%) and very few visually non-responsive RGCs (3%). In the 
P300 Tg P23H-1 retinas the portion of ON or ON-OFF RGCs (2%) was greatly 
reduced, while OFF type RGCs were still abundant in P300 Tg P23H-1 retinas 
(Figure 33). In addition, there were a large proportion of non-responsive cells in 
the P300 retinas (40%). Also of note, the total percent of OFF cells is relatively 
similar across the three groups, at ~40-45%. This indicates that RGCs are not 
changing their response characteristics, i.e. ON cells are not becoming OFF cells 
during rewiring of the retinal circuitry. It appears that the response to light onset 
is declining and producing a decrease in RGCs with either ON or ON-OFF 
responses and that as this occurs there is an increase in visually non-responsive 
cells, while the OFF pathway remains robust.  
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Differential changes in the spontaneous activity of ON and OFF RGCs in Tg 
P23H-1 rat retina.  
 In WT rat retina, no changes are evident in the spontaneous activity of any 
RGC class as the animals age. The frequency of action potentials does not 
increase with age in WT rats. No inherent peak frequency is present in the 
spontaneous firing rate either. In many retinal dystrophy models spontaneous 
activity often changes in frequency and/or pattern. For example, in mouse 
models of RP (Stasheff 2008,Trenholm et al., 2012) and congenital stationary 
night blindness (CSNB, Demas et al., 2006), changes in spontaneous activity of 
RGCs have been described in the form of bursting activity and increased overall 
activity. In RP models, these changes are correlated with the decline of 
Figure 33. The cell class profile 
for WT, P35 and P300 Tg P23H-1 
retinas.  A clear change was 
evident in the P300 animals while 
the P35 group has a very similar 
distribution as WT animals. NR = 
non-responsive RGCs 
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photoreceptors. At P300, Tg P23H-1 OFF RGCs exhibit spontaneous activity 
with a significant rhythmic component, defined by a peak F0 component when a 
fast Fourier transformation (FFT) was performed. The remaining ON and ON-
OFF RGCs did not show a significant rhythmic component (Figure 34).  
 
When comparing the peak of the FFT, which shows the primary rhythmic 
frequency if there is rhythmic firing, OFF RGCs had an average fundamental 
peak at 6.22 Hz compared to 2.92 Hz for P35 Tg P23H-1. Non-responsive P300 
RGCs also showed a fundamental peak at 5.89 Hz, but this was not significantly 
lower than OFF cells. This suggests the same mechanism is driving the bursting 
activity in these cells. ON and ON-OFF responsive cells never had any rhythmic 
activity, evident by the lack of an F0 peak in the FFT for those cells. This may 
indicate differences in circuitry that lead to an early onset of rhythmicity in OFF 
cells even though they are still receiving input, while ON or ON-OFF cells  do not 
exhibit rhythmic bursting until they become non-responsive to visual stimuli.  
OFF RGCs in both P35 and P300 Tg rats trend towards an increase in 
spontaneous activity, with an average firing rate of 9.97 and 11.07 Hz 
respectively. However, this did not reach significance compared to WT OFF cells 
at 6.61 Hz. There was a trend for a drop in ON RGC spontaneous activity for 
Figure 34. F0 peak of the fast 
Fourier transform in P300 Tg 
P23H-1 retinal cell classes.  Only 
OFF cells and NR cells exhibited 




both Tg groups compared to WT, but again this was not a significant difference. 
Sekirnjak et al. (2011) reported an increase in OFF RGC spontaneous activity 




My data differs from previously published results describing RGC function 
in the Tg P23H-1 rat (Sekirnjak et al., 2011). In light of other models of RP that 
do show a shift towards OFF dominated responses (rd1, rd10, RCS rat), they 
tested the Tg P23H-1 rat and concluded that there was no change in the ON-
OFF balance. My data show there are functional changes in both Tg P23H-1 and 
Tg S334ter-3 rat models of RP. While the Tg P23H-1 rat showed a progressive 
shift from ON to OFF dominated SC responses, SC responses in the Tg S334ter-
3 rat were OFF dominated from the earliest age. Even though the two models are 
different in this respect, there is a common loss of the ON pathway while the OFF 
pathway remains robust. This change was very robust in my experiments so this 
may be a consequence of a different experimental setup. Their stimulus was 
white noise, which consists of a randomly flickering checkerboard of small 
squares, while my stimulus was full field. 
The MEA data for Tg P23H-1 suggests that the shift to OFF dominated 
responses in the SC is due to a change in input from RGCs. This does not 
eliminate the possibility that there are reactive changes in the SC however. In 
fact, functional and structural changes in the SC of RCS rats have been reported 
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previously. Vugler and Coffey (2003) reported the loss of calretinin and 
parvalbumin immunoreactivity in SC neurons of RCS rats Pothecary et al. (2005) 
reported altered SC expression of iGluR receptors in RCS rats that led to 
changes in SC responses compared to wild type rats. These examples may be 
mutation specific but it is likely that the SC (and other areas of the visual system) 
exhibits reactive changes during the degenerative process that is not mutation 
specific. 
This functional change from ON to OFF dominated responses appears to 
be a consequence of photoreceptor degeneration in general, rather than specific 
to certain RP models. This is the fourth description of such a change and the 
third mutation (Mertk, Pde6, and now rhodopsin) in which this change is 
occurring. Similar to the Tg S334ter-3, the rd1 (Pde6 mutation) is a very rapid 
decline, yet still shows a similar preferential loss of the ON pathway. It could be 
argued that this may be specific to rodent models since all of the above 
examples are either rat or mouse but unpublished data from the McCall 
laboratory shows evidence of a similar change in a pig model of RP (also the 
P23H mutation). If this is something universal to photoreceptor degeneration, it 
may be possible to exploit this change in the clinic to either diagnose early 
stages of RP or AMD and also to assess the speed of disease progression, 
perhaps looking at changes in threshold responses of patients to light increments 
and decrements.  Renner et al. (2006) reported that there was a larger decrease 
in the ON ERG response vs. OFF response in humans with various retinal 
dystrophies thought not in RP patients. This was a small sample but does 
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support the possibility that a differential change in the ON vs. OFF pathway is 
detectable in the clinic. 
Since this functional change appears across multiple models with different 
mutations (rd1-Pde6, RCS-Mertk, P23H/S334ter –rhodopsin), a more universal 
explanation is likely to account for these changes. My hypothesis is that the loss 
of expression of mGluR receptors is a protective mechanism for ON BCs. As 
photoreceptors are lost, glutamate release onto the terminals of the horizontal 
and BC dendrites must decline. Since ON BCs respond in a sign inverting 
manner to glutamate, the absence of glutamate may keep these ON BCs in a 
depolarized condition. If this is the case and there are no compensatory 
mechanisms, the time the TrpM1 channel is in its open state should increase and 
the constant depolarized state should increase intracellular calcium potentially 
leading to excitotoxicity and eventually cell death if the depolarization is not 
corrected. As there is no precedence for a selective cell death of ON vs. OFF 
BCs, it is likely that the ON BCs may eliminate expression of the mGluR6 
receptor either by a reduction in trafficking to the cell surface or down regulation 
of expression in general. In contrast, OFF BCs express ionotropic glutamate 
receptors, which are sign conserving so the loss of glutamate is a lack of 
depolarization. In this case, there would be no excitotoxicity that would cause 
OFF BCs to stop expressing iGluR on their dendritic tips. In addition, the nob 
mouse does not show the same change glutamate receptor expression (Ball et 
al., 2003) even though there is a lack of response from ON BCs. The nob mouse 
is a model for congenital stationary night blindness in which the protein 
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nyctalopin is mutated, which is required for the localization of TrpM1 channels to 
the ON BC dendritic tips. Photoreceptors in the nob mouse are still functional, as 
evidenced by the presence of an a-wave, so BCs still receive input but this input 
no longer results in membrane voltage changes in ON BCs. This suggests that 
the mechanism depends on input from photoreceptors and the presence of a 
functional TrpM1 channel for expression to change. Without functional TrpM1 
channels, there is no depolarization in ON BCs and therefore no excitotoxicity in 
nob. Therefore, the mechanism that reduces mGluR6 expression is never 
initiated in the ON BCs of the nob mutant. I believe this supports the idea that the 
lack of input from photoreceptors is causing the reactive changes seen in RP 
models. 
These functional changes also have important implications for future 
treatments. For example, if stem cells are able to integrate into a host retina, how 
can we be certain that the retina will respond properly if there is significant 
remodeling in structure and function? If this change does represent a 
modification in the expression of glutamate receptors, as has been previously 
reported, then the release of glutamate from newly integrated photoreceptors 
may be ineffective. It’s possible that a feedback mechanism may exist if 
photoreceptors are reintroduced to the system, causing the BCs to express their 




IMPLANTATION OF RETINAL PROSTHETIC 




 When a cure is not available, an important strategy in treating 
neurodegenerative disease is to slow its progression. The mPVA device has 
been observed to exhibit neuroprotective effects by preservation of photoreceptor 
numbers (Pardue et al., 2005) and as light evoked responses recorded in the SC 
(DeMarco et al., 2007). There is evidence that electrical stimulation, in general, 
provides a neuroprotective effect with an increase in ONL thickness and ERG a-
wave and b-wave amplitude (Morimoto et al., 2005, Morimoto et al., 2007, Ni et 
al., 2009, Morimoto et al., 2012). The question remains however, does 
preservation have functional implications that have not been previously tested? 
In cases where there was preservation, the benefit was often transient, delaying 
degeneration for a short time (1-2 weeks) (Morimoto et al., 2007, Ciavatta et al., 
2009). This does not preclude the possibility that an effect on the retina still exists 
after photoreceptors are lost. This could be in the form of preservation of the 
remaining cellular layers (INL, RGC), receptor expression (mGluR, Glycine, 
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GABA), or RPE structure as RPE cells often invade other cellular layers during 
the degenerative process. The possibility of a prosthesis-mediated 
neuroprotective effect has important implications for the timing of surgery in a 
patient. If there is a long-term functional preservation of visual responses or if 
cells or the structure of the retina is preserved, it may mean implantation at an 
earlier stage of degeneration may be beneficial. Alternatively, if there is no 
protective effect, surgery may be best left until late stages of the disease when 
the risk to the patient is minimized. Although I did not perform a stimulation 
protocol in the implanted rats, it is possible that the low level of current generated 
by the implant with ambient lighting conditions may stimulate the retina enough to 
support neuroprotection.  
 
Experimental Goal 
The goal of these experiments was to determine if there is any effect on 
the visually-evoked response recorded in the SC when a prosthetic device is 
present. With the ON-OFF response changes described in Chapter III for both 
RP models, a neuroprotective effect is defined here as a significant increase in 
the function of the ON pathway. In WT, both the ON and OFF pathways are 
functional and stable with age. In both models, the OFF pathway dominates the 
degenerate retina, either early in the process (Tg S334ter-3) or as the animals 
age (Tg P23H-1). The implication for degenerative diseases, if this is a common 
symptomatic change, is that without a functional ON pathway, treatment options 
may be limited in their potential for normal vision. 
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Materials and Methods 
Animals 
 Three groups of Tg P23H-1 and Tg S334ter-3 animals were used in these 
experiments. One group of Tg P23H-1 was implanted with bPVA devices and 
tested. Two groups of Tg S334ter-3 animals were tested; one group implanted 
with bPVA devices and the other implanted with mPVA devices. 
Implantation Surgery 
 The same protocol was used as described in Chapter II. Animals were 
implanted at ~P35 for both Tg models. This age is very early in the degenerative 
process for the Tg P23H-1 rat when responses are similar to WT. Only a small 
loss of ONL thickness is evident at this age, with ~12 rows of nuclei remaining vs. 
~15 rows in WT rats. The Tg S334ter-3 responses were already significantly 
different from WT at this age, but this is as early as the rats will easily tolerate 
anesthesia and surgery to make a full recovery. In addition, there are still 3-5 
rows of nuclei at this age, allowing some degeneration to still take place before 
experiments were carried out. Tg S334ter-3 were ~P75 and Tg P23H-1 were 
~P150 at the time of recording since these time points represent when retinal 
function is significantly different from WT rats for both groups. 
 
In Vivo Electrophysiology 
 These experiments borrow elements from both Chapter II and III for the 
electrophysiology. Data was collected and analyzed in a similar fashion using an 
XCell3 Microelectrode Amplifier (FHC) into a Power 1401 data acquisition unit 
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(CED). Data was collected and stored on a computer running Spike2 (CED) and 
analyzed offline. To assess the function as it related to the region of implant 
influence, the visually evoked responses were mapped using the same hemi-field 
LED stimulus for the right eye and the IR evoked responses were mapped using 
the IR laser system. This allowed for a retinotopic map of both visual and IR 
evoked responses and for regions under the influence of the prosthesis to be 
compared to regions outside the influence of the prosthesis. To examine whether 
there is a trophic effect, Tg P23H-1 rats were implanted with a bPVA device. The 
Tg P23H-1 group was implanted with bPVA devices for this specific set of data 
while Tg S334ter-3 data was gathered from animals implanted for data in 
Chapter II. I recorded and characterized the prosthetic and visually evoked 
responses in the SC and examined whether there was evidence of a 
neurotrophic effect by comparing the visually evoked responses within animals 
depending on the proximity to PVA influence. In addition, these responses were 
compared with responses of non-implanted controls whose ages were matched 
to the age at the endpoint of implantation (~P140-150). I used full field visible 
stimuli and the IR laser and recorded these evoked responses in a systematic 
map across the SC dorsal surface. I compared visually evoked responses, which 
changed significantly with disease progression (see Chapter III for detailed 






Implantation of a bPVA device imparts a neuroprotective effect in the Tg P23H-1 
rat retina  
 In the Tg P23H-1 rat model, there is a prolonged decline in visually 
evoked responses, a change in spontaneous activity of OFF and non-responsive  
(NR) RGCs (bursting activity), as well as a shift from ON dominated responses to 
OFF dominated responses (See 
Chapter III). In vitro recordings from 
RGCs in these rats showed similar 
changes with the loss of ON 
responsive RGCs, indicating that the 
changes arise from altered retinal 
signaling and input to the SC. To 
determine if there was a functional 
neuroprotective effect of implantation, 
I divided the SC into regions based on 
how close they were to the SC area 
where IR-evoked responses could be recorded. Figure 35 shows an example of 
how these areas were calculated. Comparisons were made between areas that 
showed direct IR-evoked responses, areas adjacent to (<400 µm) PVA-
responsive sites, and areas far away from the area of PVA influence (>400). 
Figure 36 shows an example of the two topographic responses maps of a Tg 
P23H-1 SC at P140. The maps were created from the IR-evoked responses 
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Figure 35. Schematic diagram of IR, 
Near and Far site designation.  The 
red circle represents the IR 
responsive sites, the green circle 
excluding the red circle represents 
near sites (<400 µm) and outside the 
green circle are far sites (>400 µm). 
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(black and white) and visually evoked response plotted as the ON-OFF indices 
(color map with peak index value = red and lowest index value = blue). The large 
map shows the superimposition of the two individual maps. In the region of 
overlap, the ON-OFF index is highest for this animal, indicating there may be a 
correlation between the region of PVA influence and the function of the ON 
pathway. 
To evaluate whether this neurotrophic effect was confined to the are 
directly in contact with the implant or a paracrine effect that could encompass the 
entire retina, I compared the average ON-OFF index within IR responsive in the 
Tg P23H-1 SC sites to SC sites adjacent (<400 µm) or distal (≥400 µm) to this 
area in P150 animals. Figure 37 plots the ON-OFF index in relation to the PVA 
influence and shows that SC responses shift significantly towards balanced ON 
and OFF responses. Regardless of their distance from IR responsive areas, the 
areas outside of the influence of the device remained OFF dominant and did not 
differ significantly from one another. This indicates that the neurotrophic effect 
was limited to regions that are directly under the influence of the PVA, rather than 






 As described previously (Chapter III), the ON-OFF index depends on both 
peak amplitude and duration of the ON and OFF response. With this 
Figure 36.  Example SC topographic 
maps from the same Tg P23H-1 
animal.  The black and white map 
represents IR responsive sites in 
white.  The color map represents ON-
OFF index values, with the highest 
index values in red and low values in 
blue.  The maps were then 
superimposed to show the 
relationship between the IR 










Figure 37. Comparison of the 
ON-OFF index and topographic 
relationship between IR 
responsive sites (IR), sites 
adjacent to but not more than 
400 µm from the IR responsive 
area (Near), and sites greater 
than 400 µm from the IR 
responsive region (Far). .In 
bPVA implanted Tg P23H-1 
rats, regions under the 
influence of the implant were 
significantly different than 
regions outside the influence of 
the prosthesis. **p<0.01 
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dependence, it is possible that rather than a protective effect on retinal function, 
the effect could result from a decrease in the OFF response amplitude or 
duration rather than a protective effect on the retina. To evaluate how the 
presence of the prosthetic changes these aspects of the response, I compared 
the amplitude and duration of the ON and OFF SC response. Figure 39 plots the 
ON and OFF duration and peak responses as a function of region and shows a 
significant increase in the total response of the ON response while the OFF 
response was similar across areas. This suggests that the neurotrophic effect of 
the device is selective to the ON pathway. The untreated Tg group was not 
significantly different than the IR responsive areas. This may suggest there is no 
neuroprotective effect. However, this can be interpreted in different ways and is 
addressed within the discussion section below. 
Figure 38 shows that there was a significant increase in the amplitude of 
the response and a trend for the duration of the SC ON response to increase. In 
contrast, neither component of the OFF response was different. Taken together, 
there was a significant effect on the ON response in areas under the influence of 
the device while no change was seen in OFF responses regardless of the 
position relative to the bPVA. Spontaneous activity was also compared to 
determine if there was any effect on the firing rate. There was no effect across 
groups with implants, but the spontaneous activity of all regions of the SC was 
significantly lower than that of untreated, age-matched controls (Figure 39). It is 
difficult to say if this represents a protective effect as the spontaneous activity 
has been reported to change in Tg P23H-1 rats depending on the RGC cell type 
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(Sekirnjak et al., 2009). ON cells were reported to decrease their firing rate while 
OFF cells increase their spontaneous activity. Since the experiments outlined 
here are recording multicellular SC activity, it is impossible to know the functional 
class that has input to a particular area of the SC. Therefore, it cannot be 
determined if these changes are being mitigated by the PVA or if this was caused 
by another factor, such as variance between litters (implanted animals tended to 
be from the same litter). 
 
 
Figure 38.   
A. Tg P23H-1 peak amplitude comparison for the ON (left) and OFF (right) 
response. **p<0.01, ****p<0.0001 
B. Response duration comparison. No groups were significantly different 







Implantation may impart a partial recovery of the ON pathway in the Tg  
S334ter-3 rat  
 As described in Chapter III, degeneration in the Tg S334ter-3 rat is much 
more rapid than the Tg P23H-1 rat. The Tg S334ter-3 rat also showed a 
significantly different ON-OFF index from WT. Even as early as the age of 
implantation (P35), OFF responses dominated the SC response profile. Although 
this may be a significant hurdle for a neuroprotective effect, I made comparisons 
in the Tg S334ter-3 in the same manner as described for the Tg P23H-1 above. 
Figure 40 plots the ON-OFF index for regions under the influence of the PVA and 
regions outside of its influence and shows that despite the more aggressive 
nature of the Tg S334ter-3 degeneration that the prosthetic significantly 
increases the ON-OFF index in regions under its influence. There was no 
significant difference between sites that are directly adjacent (<400 µm) to the 
area of influence and areas more than 400 µm away, similar to the effect seen in 
Figure 39.  Comparison of the 
spontaneous SC activity in Tg 
P23H-1 rats as a function of 
implant influence.  No region of 
the SC had any change in 
spontaneous activity but all 
regions had lower activity than 
untreated rats. *p<0.05 
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Tg P23H-1 rats. When compared to untreated Tg animals, the ON-OFF index 
was significantly higher for regions under the influence of the PVA. 
   
Figure 41 plots the ON and OFF peak responses and response duration for Tg 
S334ter-3 rats. Though there was a significant change in the ON-OFF index, 
there was no significant change in the ON duration or peak response. There was 
a trend however, towards a higher ON peak response for sites under the 
influence of the PVA. This may be a consequence of a low n (5) and may be 
significant if the number of rats was increased. An important point to make here 
as well was the lack of change in the OFF pathway as the animals aged, the OFF 
response was consistent regardless of the measurement used. Surprisingly, the 
OFF response of the untreated animals was much larger than the OFF response 
in implanted animals. This explains the significant change in the ON-OFF index 
when compared to untreated animals. However, when the internal control regions 
are compared to the IR-responsive regions, there is a trend for an increased ON 
response in regions under the influence of the PVA and the ON-OFF index value 
was still significantly higher in regions of PVA influence. 
Figure 40.  ON-OFF index 
comparison in relation to area of 
PVA influence.  Regions under the 
influence of the PVA showed a 
significant increase in the ON-OFF 
index, even when compared to 
untreated Tg rats. **p<0.01  
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In contrast to the change in Tg P23H-1 spontaneous activity, there was no 
significant change in the spontaneous activity in Tg S334ter-3 rats either across 
regions within an implanted rat or compared to untreated age-matched Tg rats 
(Figure 42). 
Figure 41.  
A. Comparison of the ON and OFF peak response in relation to regions of 
PVA influence. No significant changes were found, though a trend towards 
larger ON responses was seen in regions of PVA influence. 
B. Comparison of the ON and OFF response duration.  The OFF response 





 My data suggest there may be a neuroprotective effect on the function of 
the retina in regions under the influence of the prosthesis. In both the Tg P23H-1 
and Tg S334ter-3 rat models show significantly larger ON-OFF indices in regions 
within IR-evoked responses, suggesting a rescue of function within the ON 
pathway. Although there are trends that indicate some change with distance, the 
significant effects appear local to the region of PVA influence. This suggests that 
the effect is either due to stimulation provided by the device, albeit low in level, or 
the presence of a foreign object. I favor the former explanation since it is local 
and not global, which would be expected from a foreign object influence. Rather, 
the data suggests there is an effect directly related to contact with the PVA. 
Whether this is a physical interface or functional contact (current spreading to 
regions away from the PVA) cannot be determined.  
My data supports the hypothesis that a prosthetic device can impart a 
neuroprotective effect by prolonging ON pathway function, especially in the 
Figure 42. Spontaneous 
activity in implanted and 
untreated Tg S334ter-3 rats.  
No significant change in 
spontaneous activity was 
seen. 
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slower degenerating Tg P23H-1 rat. The results in Tg S334ter-3 rats were not 
conclusive but this may be due to the length of the implantation. In the Tg P23H-
1 rats, the implant was left in the eye for ~115 days while in Tg S334ter-3 rats, it 
was only in the eye for ~40 days. The effect may simply require a longer duration 
of implantation than the 40 days used here. This time point was chosen because 
the degeneration is much more rapid in the Tg S334ter-3, so it can be a difficult 
balance finding an age with robust visually-evoked responses and the 
implantation duration. This may be why there was simply a trend for increased 
ON pathway function rather than significant difference.  
In patients, if implantation enhances the maintenance of retinal function, 
the long term prognosis for patients, regardless of treatment, will be better. The 
data suggest it may be beneficial to implant these devices earlier in the 
degenerative process, as the function of the ON pathway may be spared. 
Importantly, there was no detrimental effect of the OFF pathway response with 
implantation in the Tg P23H-1 rats, leading to the conclusion that there is a 
general beneficial effect of implantation. While not as compelling, there still was a 
trend within the ON pathway and a significant increase in the ON-OFF index of 
IR responsive regions in Tg S334ter-3 rats. When taken together with the data in 
Chapter III, the larger ON responses in implanted animals supports the 
maintenance and/or recovery of the ON pathway, with no discernible latency in 
the loss of visually evoked responses. This does not preclude the possibility that 
an effect on the retina still exists after photoreceptors are lost. This could be in 
the form of preservation of the remaining cellular layers (INL, RGC), receptor 
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expression (mGluR, Glycine, GABA), or RPE structure as RPE cells often invade 
other cellular layers during the degenerative process. 
An argument could be made that the presence of the devices actually 
seemed to be detrimental to the function of the retina based on the comparison 
to untreated Tg animals. Indeed, there was no significant difference in any 
measure between regions under PVA influence when compared to untreated 
controls. However, this may be explained by light damage during the implantation 
surgery. Multiple studies have shown that increased exposure to light, even 
under normal ambient intensities, accelerates the degenerative process in both 
RP models used here (Organisciak et al., 2003, Vaughan et al., 2003, Jozwick et 
al., 2006, Thomas et al., 2007). In fact, even an exposure to bright light as short 
as 1 hour has been reported to significantly accelerate photoreceptor 
degeneration in the Tg P23H-1 rat (Vaughan et al 2003). In light of these reports, 
it is likely that the light used to illuminate the eye during the implantation surgery 
negatively affected the retina in implanted animals. The surgery typically lasted 
~45 minutes, which is a significant amount of time to have a bright light illuminate 
the eye. Vaughan et al. (2003) exposed two lines each of Tg P23H-1 and Tg 
S334ter-3 rats to intense light (1200-1400 cd/m2) for 1-8 hours. The light source 
used for implantation surgery was very bright, somewhere between 1100 and 
10,000 cd/m2, certainly enough light to damage the retina. Unfortunately, the 
experimental setup did not allow for comparison to the non-implanted (and 
presumably non-light damaged) eye as the stereotaxic apparatus physically 
impeded the ability to direct the full field light source on the opposite eye. Bearing 
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this in mind, the most effective comparison would be within the same eye, 
comparing areas under PVA influence to areas outside of its influence. When 
these regions are compared, Tg P23H-1 ON pathway function is significantly 
larger within the PVA influenced area. Although not statistically significant, the 
trend is the same in Tg S334ter-3 rats. 
 DeMarco et al (2007) reported trophic effects of implantation of mPVAs in 
RCS rats. First, visual responses were more robust in areas under the influence 
of the mPVA. Secondly, there was an increase in the number of visual 
responsive SC sites even in regions that were not correlated with the likely 
position of the prosthesis. This may be due to a more global response to either 
the surgery or foreign body response to the prosthesis. The global response 
could be an increase in trophic factors, such as Fgf2 as reported by Ciavatta et 
al. (2009) in the RCS rat. While an increase in trophic factors cannot be ruled out 
for my data, there was no observable delay in the loss of visual responses. My 
data support an alternative hypothesis. Since the effect was localized to area 
under the influence of the PVA, it is more likely that the current generated by the 
prosthesis results in the functional neuroprotection. While the devices are not 
producing enough current to elicit PVA-evoked responses to ambient light, they 
still produce current in response to ambient light (see Figure 10), albeit at a much 
reduced level. The rats are housed in a normal 12/12 light-dark cycle, so there 
are up to 12 hours each day that the devices are producing some basal level of 
current. In addition, in both Tg models, the only areas that showed a significant 
increase in the ON-OFF index were the areas directly under the influence of the 
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device. This does not rule out the possibility that the electrical current elicits an 
increase in trophic factors directly where it sits in the retina, but regardless, the 
effect was tied to a functional connection with the bPVA. This is consistent with 
reported neuroprotection using trans-corneal electrical stimulation in RCS rats 
where there was a preservation of both numbers of photoreceptors and ERG 
amplitudes in treated animals (Morimoto et al., 2007). It should be noted that the 
RCS rat and its photoreceptor degeneration is caused by a very different 
mechanism. Specifically, in the RCS rat the cells of the retinal pigment epithelium 
are dysfunctional and fail to phagocytize disks shed from the outer segment of 
photoreceptors. This leads to a buildup of debris in the subretinal space and a 
cascade of events ending in photoreceptor death. As a consequence, the effect 
of implantation may have quite different trophic effects.  
The important question remains, however, what is the underlying cause of 
the neuroprotective effect? Does electrical stimulation cause an increase in 
trophic factors and if so, which ones? Does electrical current act directly on BCs 
to change their membrane potential and if so, does it close or open ion channels 
and which ones (excitatory at the dendritic or axonal tips or inhibitory at the 
axonal tips)? If the hypothesis for the loss of the ON pathway described in 
Chapter III is correct, then I believe my results support the theory that electrical 
current acts directly on the retina, likely hyperpolarizing BCs through some 
mechanism. This could prevent a reactive (excitotoxic or other) mechanism that 
reduces the expression of mGluR6. Regardless, the data suggest that the 
implant itself prevents the loss of the ON pathway in both of these models of RP. 
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CHAPTER V 
SUMMARY AND FUTURE DIRECTIONS 
In summary, Chapter II described the retina-prosthesis interface with the 
following conclusions: 
1. Targeted prosthesis stimulation yields a high success rate for retinal activation. 
2. Synaptic blocker injections show PVA-evoked responses are mediated  
    through INL neurons rather than through direct activation of RGCs. 
3. Activation in the SC is generally correlated to the location of the device in the  
    eye. 
4. Implantation age and duration had no effect on threshold for stimulation. 
5. Pixel size in bPVA devices did not affect threshold but bPVA devices had a 
significantly higher threshold for activation than mPVA devices. 
6. All thresholds for activation were below established safety limits for the retina. 
7. A linear range of increasing PVA-mediated responses was present. 
8. Focal activation of the retina was possible with bPVA devices but not mPVA 
devices. 
9. The bPVA device design represents a significant improvement in prosthesis 
design of the mPVA design. 
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  One of the major hurdles to treating RP is the heterogeneity in the cause 
of the disease. The cost for a company to develop genetic treatments for every 
cause of RP is not cost effective for these companies. More comprehensive 
treatments that are independent of the cause are most likely to be developed on 
a commercial basis. To this end, the use of prosthetic devices, stem cells, and 
optogenetic tools likely represent the most promising options. When safety 
concerns are considered, currently prosthetic devices have been deemed safe by 
the FDA while both stem cells and optogenetic manipulation still have concerns 
and questions that have yet to be addressed. In addition, the state of the retina 
may guide which treatments will be most effective for a given patient. If BCs are 
unable to faithfully transmit signals mediated by glutamate, prosthetic devices will 
still work at either the BC or RGCs level. 
The Argus II system developed by Second Sight, Inc. is an epiretinal 
design that is the only retinal prosthesis to be approved by the FDA. It has a 
proven track record with years of research to back up its safety and efficacy. 
However, the best resolution achieved with this device is quite poor, only 
reaching 20/1260. The prosthesis group in Germany led by Dr. Zrenner has 
achieved a much higher resolution (20/560) with their subretinal implant. 
However, both systems rely on an external power supply. Both of these issues 
are addressed by the bPVA design. It is a subretinal chip that has the potential 
for high acuity vision while being completely self-contained. The debate between 
subretinal and epiretinal prosthetic designs is still ongoing with both systems 
 89 
having their advantages and disadvantages. In my opinion, subretinal stimulation 
using a photovoltaic array offers the best design for a retinal prosthetic device.  
The future of the retinal prosthesis field will undoubtedly be higher 
resolution designs. A thorough understanding of what vision is possible with 
visual prosthetics will also drive future designs and stimulus protocols. While 
forms, luminance and rudimentary motion can be encoded by current designs, 
the visual system encodes much more information than these basic perceptions. 
Can other facets of vision be faithfully encoded such as color vision, depth 
perception, and ON/OFF signals? Regardless of this outcome to these questions, 
prosthetic devices have been proven safe, can transmit information to completely 
blind patients, and have long term stability.  
 
Chapter III described functional changes associated with photoreceptor 
degeneration and concluded the following: 
1. In the Tg P23H-1 rat model of RP, there is a shift in SC responses from ON 
dominated to OFF dominated that increases as a function of age. 
2. In the Tg S334ter-3 rat model of RP, SC responses are strongly OFF 
dominated from a very early age likely due to the rapid nature of this model’s 
degeneration. 
3. MEA recordings in Tg P23H-1 rat retina indicate that the progressive changes 
are caused by the loss of ON signaling within the retina rather than changes 
within the SC. 
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4. An increase in spontaneous activity and rhythmic activity in Tg P23H-1 RGCs 
are only seen in OFF and NR RGCs once photoreceptors have begun to 
degenerate. 
 
 The functional consequences of photoreceptor degeneration have not 
been extensively explored. The state of the retina during the degenerative 
process may have profound effects on the potential for certain treatments to be 
effective. If we can categorize these changes, future research can work to either 
prevent or reverse these changes and better treat patients with degenerative 
diseases such as RP and AMD. In addition, studying the reactive changes in the 
retina may be beneficial towards understanding plasticity within the retina. Other 
species, such as chickens (Fisher, 2005) and frogs (Filoni, 2009), are able to 
regenerate cells within the retina if they are damaged. Some of the processes 
that occur during the degenerative process may be common to proliferative or 
developing cells. In this regard, studying the mechanisms of these reactive 
changes may help discover why mammalian retinas (and neurons in general) are 
unable to regenerate and how plasticity in the retina may be encouraged and 
utilized.  
  
 Chapter IV described a possible functional neuroprotective mechanism 
through implantation of a prosthetic device with the following conclusions: 
1. Implantation of bPVA devices significantly increased the function of the ON 
pathway in Tg P23H-1 rats.  
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2. The effect was present only in SC regions that were under the influence of the 
PVA. 
3. Implantation in Tg S334ter-3 rats showed a similar trend for an increased ON 
response but only was significantly different when analyzing the ON-OFF index. 
 Electrical stimulation of the retina may be an effective neuroprotective 
mechanism, whether applied directly to the retina or by stimulating the whole 
eye. The functional recovery described in this chapter was only present in 
regions under the influence of the PVA. This suggests that this example of 
functional neuroprotection may not be possible using external stimulation of the 
retina. If the current was increased, this may be enough to see a similar effect. 
The results with the Tg S334ter-3 rats were not as strong as in implanted Tg 
P23H-1 rats, but as previously discussed, this may be due to the difference in 
implantation duration. Alternatively, the rapid degeneration and loss of the ON 
pathway in the Tg S334ter-3 may prevent electrical stimulation from being 
effective in this model. For the majority of RP patients, this is a slow process with 
many patients not being severely impaired until late in life. As such, the Tg P23H-
1 rat probably represents a more analogous model of RP than the Tg S334ter-3. 
If the effect is truly mediated by the current generated by the device, the next 
logical step would be to actively stimulate the device with IR light over the course 
of a few weeks (or months) to see if the effect is related to the amount of current 
generated by the PVA. This may enhance the effect and increase the ON 
response even further. In addition, even if the progression of the disease is not 
slowed or halted, if the retinal circuitry is spared during the degenerative process, 
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such as the expression of mGluR6 on BCs, this can increase the treatment 
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